UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

MARK ONE

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the Quarterly Period ended March 31, 2024;

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the transition period from ________ to ________

 

ZION OIL & GAS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   20-0065053
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
12655 N Central Expressway, Suite 1000, Dallas, TX   75243
(Address of principal executive offices)   Zip Code

  

(214) 221-4610

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No

 

As of May 6, 2024, Zion Oil & Gas, Inc. had outstanding 733,547,697  shares of common stock, par value $0.01 per share.

 

 

 

 

 

 

INDEX PAGE

 

    Page
PART I — FINANCIAL INFORMATION
     
Item 1 – Financial Statements – Unaudited    
     
Consolidated Condensed Balance Sheets – March 31, 2024 and December 31, 2023   1
     
Consolidated Condensed Statements of Operations for the three months ended March 31, 2024 and 2023   2
     
Consolidated Condensed Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2024 and 2023   3
     
Consolidated Condensed Statements of Cash Flows for the three months ended March 31, 2024 and 2023   4
     
Notes to Consolidated Condensed Financial Statements   6
     
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations   35
     
Item 3 – Quantitative and Qualitative Disclosures About Market Risk   44
     
Item 4 – Controls and Procedures   44
     
PART II — OTHER INFORMATION
     
Item 1 – Legal Proceedings   45
     
Item 1A – Risk Factors   45
     
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds   45
     
Item 3 – Defaults upon Senior Securities   45
     
Item 4 – Mine Safety Disclosures   45
     
Item 5 – Other Information   45
     
Item 6 – Exhibits   46
     
Exhibit Index   46
     
SIGNATURES   47

 

i

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Balance Sheets as of

 

   March 31,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
   (unaudited)     
Current assets        
Cash and cash equivalents   1,115    615 
Fixed short term bank and escrow deposits – restricted   1,031    1,020 
Prepaid expenses and other   415    515 
Governmental receivables   27    18 
Other receivables   445    123 
Total current assets   3,033    2,291 
           
Unproved oil and gas properties, full cost method (see Note 4)   16,943    16,637 
           
Property and equipment at cost          
Drilling rig and related equipment, net of accumulated depreciation of $2,405 and $2,215 (see note 2I)   5,319    5,510 
Property and equipment, net of accumulated depreciation of $693 and $686   75    74 
    5,394    5,584 
           
Right of Use Lease Assets (see Note 5)   956    194 
           
Other assets          
Assets held for severance benefits   489    475 
Total other assets   489    475 
           
Total assets   26,815    25,181 
           
Liabilities and Stockholders’ Equity          
           
Current liabilities          
Accounts payable   674    777 
Insurance financing (see note 6D)   388    432 
Lease obligation – current (see Note 5)   224    167 
Asset retirement obligation   571    571 
Accrued liabilities   617    693 
Total current liabilities   2,474    2,640 
           
Long-term liabilities          
Lease obligation – non-current (see Note 5)   708    24 
Provision for severance pay   506    499 
Total long-term liabilities   1,214    523 
           
Total liabilities   3,688    3,163 
           
Commitments and contingencies (see Note 6)   
 
    
 
 
           
Stockholders’ equity          
Common stock, par value $.01; Authorized: 1,200,000,000 shares at March 31, 2024: Issued and outstanding: 709,445,335 and 640,002,580 shares at March 31, 2024 and December 31, 2023, respectively   7,094    6,400 
Additional paid-in capital   304,354    302,177 
Accumulated deficit   (288,321)   (286,559)
Total stockholders’ equity   23,127    22,018 
           
Total liabilities and stockholders’ equity   26,815    25,181 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

1

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statements of Operations (Unaudited)

 

   For the three months ended 
   March 31, 
   2024   2023 
   US$
thousands
   US$
thousands
 
   (Unaudited)   (Unaudited) 
General and administrative   1,175    1,503 
Other   599    583 
Post impairment of unproved oil and gas properties   
-
    45 
Loss from operations   (1,774)   (2,131)
           
Other expense, net          
Foreign exchange (loss)   21    (2)
Financial (expenses), net   (9)   (6)
           
Loss, before income taxes   (1,762)   (2,139)
Income taxes   
-
    
-
 
           
Net loss   (1,762)   (2,139)
           
Net loss, per share of common stock          
Basic and diluted (in US$)
   (0.00)   (0.00)
           
Weighted-average shares outstanding          
Basic and diluted (in thousands)
   667,023    531,023 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

2

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited)

 

For the three months ended March 31, 2024 

 

   Common Stock   Additional
paid-in
   Accumulated     
   Shares   Amounts   Capital   Deficit   Total 
   thousands  

US$

thousands

  

US$

thousands

  

US$

thousands

  

US$

thousands

 
Balances as of December 31, 2023   640,002    6,400    302,177    (286,559)   22,018 
Funds received from sale of DSPP units and shares and exercise of warrants   69,372    693    2,864    
    3,557 
Costs associated with the issuance of shares       
    (816)   
    (816)
Funds received from option exercises   71    1    6    
    7 
Value of options granted to employees, directors and others as non-cash compensation       
    123    
    123 
Net loss       
    
    (1,762)   (1,762)
Balances as of March 31, 2024   709,445    7,094    304,354    (288,321)   23,127 

 

For the three months ended March 31, 2023 

 

   Common Stock   Additional
paid-in
   Accumulated     
   Shares   Amounts   Capital   deficit   Total 
   Thousands  

US$

thousands

  

US$

thousands

  

US$

thousands

  

US$

thousands

 
Balances as of December 31, 2022   524,231    5,242    296,460    (278,602)   23,100 
Funds received from sale of DSPP units and shares and exercise of warrants   9,357    94    698    
    792 
Funds received from option exercises   125    1    7    
    8 
Value of options granted to employees, directors and others as non-cash compensation       
    417    
    417 
Net loss       
    
    (2,139)   (2,139)
Balances as of March 31, 2023   533,713    5,337    297,582    (280,741)   22,178 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

3

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statements of Cash Flows (Unaudited)

 

   For the three months ended
March 31,
 
   2024   2023 
   US$
thousands
   US$
thousands
 
   (Unaudited)   (Unaudited) 
Cash flows from operating activities        
Net loss   (1,762)   (2,139)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Depreciation   192    200 
Amortization of Right of Use Lease Assets   67    67 
Cost of options issued to employees, directors and others as non-cash compensation   123    417 
Post impairment of unproved oil and gas properties   
-
    45 
Change in assets and liabilities, net:          
Other deposits   
-
    328 
Prepaid expenses and other   100    19 
Governmental receivables   (9)   241 
Other receivables   (322)   4 
Lease obligation – current and non-current   (88)   (71)
Severance payable, net   (7)   3 
Accounts payable   (130)   26 
Accrued liabilities   (167)   (57)
Net cash used in operating activities   (2,003)   (917)
           
Cash flows from investing activities          
Acquisition of property and equipment   (7)   
-
 
Investment in unproved oil and gas properties   (317)   (838)
Net cash used in investing activities   (324)   (838)
           
Cash flows from financing activities          
Proceeds from exercise of stock options   7    8 
Costs paid related to the issuance of new shares   (726)   
-
 
Proceeds from issuance of stock and exercise of warrants   3,557    792 
Net cash provided by financing activities   2,838    800 
           
Net (decrease)/increase in cash, cash equivalents and restricted cash   511    (955)
Cash, cash equivalents and restricted cash – beginning of period   1,635    3,114 
Cash, cash equivalents and restricted cash – end of period   2,146    2,159 
           
Supplemental schedule of cash flow information          
           
Non-cash investing and financing activities:          
Depreciation of oil and gas equipment   5    
-
 
Unpaid investments in oil & gas properties   659    1,515 
Unpaid costs of issuance during 2024   90    
-
 
Addition of right of use lease assets and lease obligations   829    
-
 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

4

 

 

Cash, cash equivalents and restricted cash, are comprised as follows:

 

   March 31,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Cash and cash equivalents   1,115    615 
Restricted cash included in fixed long-term bank deposits   1,031    1,020 
    2,146    1,635 

 

5

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 1 - Nature of Operations, Basis of Presentation and Going Concern

 

A. Nature of Operations  

 

Zion Oil & Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is an oil and gas exploration company with a history of 24 years of oil & gas exploration in Israel. As of March 31, 2024, the Company has no revenues from its oil and gas operations.

 

Zion maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland. The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is to operate a foreign treasury center for the Company.

 

On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.

 

Zion has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition, Zion has the trademark filed with the Israeli Trademark Office in Israel.

 

Exploration Rights/Exploration Activities

 

New Megiddo Valleys License 434 (“NMVL 434”)

  

On September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil and gas exploration on approximately 75,000 acres or 302 square kilometers. This Exploration License 434 is valid for three years until September 13, 2026 with four potential 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes our previous NML 428.

  

On February 21, 2024, members of the Supervisory Committee visited our rig site. During this visit, they interacted with staff from Zion Oil & Gas, and our consultants and potential service providers. Some of these interactions occurred at Kibbutz Sde Eliyahu, while others were conducted through video conferencing with participants from the United States, Europe and the Middle East. Following these discussions, the Committee has officially accepted our work plan for the MJ-01 project. This acceptance allows us to sign agreements and secure mobilization dates with our service providers required to commence and complete the project.

 

We have begun working on visa applications for our rig crew in preparation for their entry into Israel. Upon the completion of the work visa process, the crew will travel to Israel and begin inspecting the rig to make sure it conforms to industry requirements for workover operations. Afterwards, the crew will rig down, slide the drilling rig over several meters and rig up on the MJ-01 well location. The crew will then open the well and continue to follow the approved work plan in conjunction with the selected service providers. This should occur toward the end of Q2 or early Q3 depending on subsurface conditions encountered during the reopening phase and contractor scheduling availability.

 

We have made strategic adjustments to control both cost and time. Despite the typical delays during Passover, which this year began on the evening of April 22nd and ended on the evening of April 30th, we have satisfied all regulatory requirements necessary to commence operations, including, as previously mentioned, approval by the Supervisory Committee. We are ready and moving forward.

 

6

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 1 - Nature of Operations, Basis of Presentation and Going Concern (cont’d)

 

B. Basis of Presentation  

 

The accompanying unaudited interim consolidated condensed financial statements of Zion Oil & Gas, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The year-end balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the operating results for the year ending December 31, 2024 or for any other subsequent interim period.

 

C. Going Concern  

 

The Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial production of hydrocarbons. 

 

The Company’s ability to continue as a going concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately generating profitable operations from its oil and natural gas interests in the future. The Company’s current operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern may be in doubt. The consolidated condensed financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. During the three months ended March 31, 2024, the Company incurred a net loss of approximately $1.8 million and had an accumulated deficit of approximately $288 million. These factors raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date the financials were issued.

 

To carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is not, the Company may be forced to curtail or cease exploration and development activities. The consolidated condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

 

7

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies

 

A. Net Loss per Share Data 

 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share for 2024 as the inclusion of 26,965,575 in stock options and 29,456,952 in warrants would be anti-dilutive.

 

Diluted net loss per share is the same as basic net loss per share for 2023 as the inclusion of 14,901,250 in stock options and 35,096,362 in warrants would be anti-dilutive.

 

B. Use of Estimates 

 

The preparation of the accompanying unaudited consolidated condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated condensed financial statements in future periods.

 

The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated condensed financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. We have made the same estimates as to the potential impact the Israel-Hamas war may have on our operations. Actual results may differ from these estimates.

 

C. Oil and Gas Properties and Impairment  

 

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

8

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

During the three months ended March 31, 2024, the Company did not record any post-impairment charges.

 

During the three months ended March 31, 2023, the Company recorded post-impairment charges of $45,000.

 

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $16,943,000 and $16,637,000 as of March 31, 2024 and December 31, 2023, respectively.

 

D. Fair Value Measurements  

 

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

 

Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

 

Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

The Company’s financial instruments, including cash and cash equivalents, other receivables. accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2024, and December 31, 2023, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.  

 

9

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

E. Stock-Based Compensation  

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated condensed financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

F. Warrants  

 

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

 

G. Related parties  

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.

 

Zion did not have any related party transactions for the periods covered in this report.

 

10

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

H. Recently Adopted Accounting Pronouncements  

 

In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies for fiscal years beginning after December 15, 2022 with early application permitted. Zion adopted ASU 2020-03 in the first quarter of 2023. The adoption of this ASU did not have any impact on its consolidated condensed financial statements.

 

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires companies to apply the definition of a performance obligation under ASC 606 to recognize and measure contract assets and contract liabilities relating to contracts with customers acquired in a business combination. Prior to the adoption of this ASU, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. The ASU results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. Zion adopted ASU 2021-08 in the first quarter of 2023. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements; the impact in future periods will be dependent upon the contract assets acquired and contract liabilities assumed in any future business combinations.

 

In September 2022, the FASB issued ASU No. 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-50). The ASU requires companies to disclose information about supplier finance programs, including key terms of the program, outstanding confirmed amounts as of the end of the period, a roll forward of such amounts during each annual period, and a description of where the amounts are presented. The new standard does not affect the recognition, measurement, or financial statement presentation of supplier finance obligations. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods, except for roll forward information, which is effective for fiscal years beginning after December 15, 2023. The adoption of this ASU did not have any impact on its consolidated condensed financial statements.

 

Other Recent Accounting Pronouncements

 

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2024 had a significant impact on our consolidated condensed financial position, results of operations, or cash flow.

 

11

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

I. Depreciation and Accounting for Drilling Rig and Related Equipment  

 

Zion purchased an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion is depreciating the rig on a straight-line basis.

 

Zion uses the First In First Out (“FIFO”) method of accounting for the spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the spare parts gets consumed.

 

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

 

See the table below for a reconciliation of the rig-related activity during the quarter ended March 31, 2024:

 

I-35 Drilling Rig & Associated Equipment:

 

   Three-month period ended March 31, 2024 
   I-35
Drilling
Rig
   Rig
Spare Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   
-
    
-
    
-
    
-
 
Asset Depreciation   (159)   
-
    (32)   (191)
Asset Disposals for Self-Consumption   
-
    
-
    
-
    
-
 
March 31, 2024   4,432    608    279    5,319 

 

12

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity

 

The Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 800,000,000 shares to 1,200,000,000 shares, effective June 7, 2023.

 

A. 2021 Omnibus Incentive Stock Option Plan 

 

Effective June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares of common stock.

 

The Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments under certain conditions.

 

The compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award, when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable for a period not to exceed ten years from the date of grant.

 

During the three months ended March 31, 2024, the Company granted the following options from the 2021 Equity Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

i.Options to purchase 175,000 shares of Common Stock to five senior officers and two staff members at an exercise price of $0.07 per share. The options vested upon grant and are exercisable through January 4, 2034. The fair value of the options at the date of grant amounted to approximately $11,000.

 

ii.Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2034. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,800.

 

13

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

During the three months ended March 31, 2023, the Company granted the following options from the 2021 Equity Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

i.Options to purchase 175,000 shares of Common Stock to five senior officers and one staff member at an exercise price of $0.0615 per share. The options vested upon grant and are exercisable through January 4, 2033. The fair value of the options at the date of grant amounted to approximately $9,000.

 

ii.Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,500.

 

B. Stock Options  

 

The stock option transactions since January 1, 2024 are shown in the table below:

 

   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2023   34,091,250    0.23 
           
Changes during 2024 to:          
Granted to employees, officers, directors and others   200,000    0.07 
Expired/Cancelled/Forfeited   (250,000)   2.31 
Exercised   (70,675)   0.10 
Outstanding, March 31, 2024   33,970,575    0.22 
Exercisable, March 31, 2024   26,965,575    0.25 

 

14

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The following table summarizes information about stock options outstanding as of March 31, 2024:

 

Shares underlying outstanding options (non-vested)  Shares underlying outstanding options (fully vested) 
Range of
exercise
price
  Number
outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
   Range of
exercise
price
   Number
Outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
 
US$          US$   US$           US$ 
0.07   7,005,000    9.48    0.07                 
   
    
    
    0.01    5,000    0.20    0.01 
   
    
    
    0.01    20,000    2.18    0.01 
   
    
    
    0.01    130,000    2.76    0.01 
   
    
    
    0.01    50,000    2.76    0.01 
   
    
    
    0.01    60,000    3.05    0.01 
   
    
    
    0.01    200,000    3.14    0.01 
   
    
    
    0.01    40,000    3.50    0.01 
   
    
    
    0.01    70,000    3.76    0.01 
   
    
    
    0.01    25,000    3.76    0.01 
   
    
    
    0.01    30,000    3.92    0.01 
   
    
    
    0.01    4,000    4.02    0.01 
   
    
    
    0.01    25,000    4.77    0.01 
   
    
    
    0.01    35,000    5.47    0.01 
   
    
    
    0.01    150,000    5.64    0.01 
   
    
    
    0.01    35,000    5.77    0.01 
   
    
    
    0.01    75,000    6.77    0.01 
   
    
    
    0.01    200,000    7.14    0.01 
   
    
    
    0.01    300,000    7.30    0.01 
   
    
    
    0.01    10,000    7.42    0.01 
   
    
    
    0.01    500,000    7.77    0.01 
   
    
    
    0.01    55,000    7.80    0.01 
   
    
    
    0.01    960,000    8.05    0.01 
   
    
    
    0.01    75,000    8.37    0.01 
   
    
    
    0.01    10,000    8.43    0.01 
   
    
    
    0.01    795,000    8.49    0.01 
               0.01    25,000    8.77    0.01 
               0.01    10,000    9.43    0.01 
               0.01    895,000    9.48    0.01 
               0.01    25,000    9.77    0.01 
   
    
    
    0.06    50,000    8.77    0.06 
   
    
    
    0.07    25,000    9.19    0.07 
               0.07    125,000    9.77    0.07 
   
    
    
    0.14    240,000    7.80    0.14 
   
    
    
    0.15    3,200,000    7.77    0.15 
               0.15    6,389,325    8.05    0.15 
   
    
    
    0.16    340,000    1.70    0.16 
   
    
    
    0.16    75,000    5.70    0.16 
   
    
    
    0.18    25,000    1.67    0.18 
               0.18    5,155,000    8.49    0.18 
   
    
    
    0.24    25,000    8.34    0.24 
   
    
    
    0.24    118,000    8.37    0.24 
   
    
    
    0.25    50,000    7.42    0.25 
   
    
    
    0.25    363,000    7.42    0.25 
   
    
    
    0.28    25,000    1.43    0.28 
               0.28    25,000    5.43    0.28 
   
    
    
    0.29    25,000    3.21    0.29 
   
    
    
    0.39    1,435,000    7.28    0.39 
   
    
    
    0.59    1,400,000    3.14    0.59 
   
    
    
    0.59    1,600,000    7.14    0.59 
   
    
    
    0.92    350,000    2.76    0.92 
   
    
    
    0.92    550,000    6.77    0.92 
   
    
    
    1.38    105,307    0.76    1.38 
   
    
    
    1.67    405,943    0.50    1.67 
   
    
    
    1.78    25,000    0.43    1.78 
   
    
    
    4.15    25,000    0.25    4.15 
0.07   7,005,000    
 
    0.07    0.01-4.15    26,965,575         
0.25

  

15

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Granted to employees 

 

The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the three months ended March 31, 
   2024   2023 
Weighted-average fair value of underlying stock at grant date  $0.07   $0.06 
Dividend yields   
    
 
Expected volatility   133%   137%
Risk-free interest rates   3.97%   3.85%
Expected lives (in years)   5.00    5.00 
Weighted-average grant date fair value  $0.07   $0.06 

 

C. Compensation Cost for Warrant and Option Issuances  

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:

 

For the three months ended March 31, 
2024   2023 
US$ thousands   US$ thousands 
 122    415 

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:

 

For the three months ended March 31, 
2024   2023 
US$ thousands   US$ thousands 
 1    2 

 

The following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and capitalized to Unproved Oil & Gas properties:

 

For the three months ended March 31,  
2024     2023  
US$ thousands     US$ thousands  
       

 

As of March 31, 2024, there was $211,000 of unrecognized compensation cost related to non-vested stock options granted under the Company’s various stock option plans. That cost is expected to be recognized during 2024.

 

16

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

D. Dividend Reinvestment and Stock Purchase Plan (“DSPP  ”)

 

On March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three-year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of May 2, 2023, any outstanding ZNWAD warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of May 1, 2023, any outstanding ZNWAE warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of August 14, 2023, any outstanding ZNWAF warrants expired.

 

On December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January 8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of January 8, 2024, any outstanding ZNWAG warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 2, 2021 to April 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of April 2, 2023, any outstanding ZNWAH warrants expired.

 

17

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 29, 2023, any outstanding ZNWAJ warrants expired.

  

On September 15, 2020, the Company extended the termination date of the ZNWAK warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of February 25, 2023, any outstanding ZNWAK warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of August 26, 2023, any outstanding ZNWAL warrants expired.

 

Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022.

 

On March 21, 2022, the Company extended the termination date of the ZNWAM warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023 and revised the exercise price to $0.05. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On June 16, 2023, the Company extended the termination date of the ZNWAM warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2023, the Company extended the termination date of the ZNWAM warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 19, 2023, the Company extended the termination date of the ZNWAM warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On December 18, 2023, the Company extended the termination date of the ZNWAM warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On March 28, 2024, the Company extended the termination date of the ZNWAM warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

The ZNWAN warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.

 

As of May 16, 2023, any outstanding ZNWAN warrants expired.

 

18

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The ZNWAO warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.

 

As of June 12, 2023, any outstanding ZNWAO warrants expired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of a Unit (shares of stock and warrants) to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25.

 

On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

During the second quarter of 2022, all warrants represented by ZNWAP and ZNWAR were exercised resulting in a net cash inflow of approximately $365,000.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued on May 5, 2022 and were exercisable through July 15, 2023 at a revised per share exercise price of $.05.

 

Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On June 16, 2023, the Company extended the termination date of the ZNWAQ warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2023, the Company extended the termination date of the ZNWAQ warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 19, 2023, the Company extended the termination date of the ZNWAQ warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

  

19

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

On December 18, 2023, the Company extended the termination date of the ZNWAQ warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On March 28, 2024, the Company extended the termination date of the ZNWAQ warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 during 2021 in equity issuance costs to an outside party related to this waiver program.

 

On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

During the second quarter of 2022, all warrants represented by ZNWAP and ZNWAR were exercised resulting in a net cash inflow of approximately $365,000.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a revised per share exercise price of $.25.

 

 

20

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on September 30, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAT.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on December 31, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAU.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a program consisting of shares of stock to a participant. After conclusion of the program on August 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Zion incurred $173,000 in equity issuance costs to an outside party related to this waiver program. The Company executed two additional Waiver Term Sheets with a participant consisting of shares of stock. After conclusion of the program on December 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. During the year ended December 31, 2023, Zion incurred $1,120,000 in equity issuance costs.

 

On January 1, 2024, the Company executed a Waiver Term Sheet with a participant consisting of shares of stock. After conclusion of the program on March 31, 2024, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. During the quarter ended March 31, 2024, Zion incurred $816,000 in equity issuance costs. During the quarter ended March 31, 2023, Zion did not incur any equity issuance costs.

 

On April 1, 2024, the Company executed its latest Waiver Term Sheet with a participant consisting of shares of stock. This latest Waiver Term Sheet terminates at the earlier of: (a) a maximum purchase of $10,000,000 through the DSPP, (b) October 1, 2024 or (c) the closing price of Zion’s stock is 15 cents per share for five (5) consecutive days.

 

During 2024, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 59% of the net cash raised through the DSPP. 

 

During 2023, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 54% of the net cash raised through the DSPP.

 

On March 13, 2023, Zion filed with the Securities and Exchange Commission an Amendment No. 2 to the Prospectus Supplement dated as of December 15, 2021 and accompanying base prospectus dated December 1, 2021 relating to the Company’s Dividend Reinvestment and Direct Stock Purchase Plan. The Prospectus forms a part of the Company’s Registration Statement on Form S-3 (File No. 333-261452), as amended, which was declared effective by the SEC on December 15, 2021.

 

21

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Amendment No. 2 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under Amendment No. 2. Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 2 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option had up to three tranches of investment, in which the second and third tranches were each subject to termination upon a total of $7,500,000 received from participants by the Company during the first or second tranche. The first tranche period began on March 13, 2023 and terminated on March 26, 2023. The second tranche began on March 27, 2023 and terminated on April 9, 2023 and the third tranche began on April 10, 2023 and terminated on April 27, 2023.

 

The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional five hundred (500) shares of Common Stock at a per share exercise price of $0.05. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.05. The warrant shall have the Company notation of “ZNWAV” under the first tranche, “ZNWAW” under the second tranche and “ZNWAX” under the third tranche.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price of $0.05 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and shall have the Company notation of “ZNWAY.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they purchased at least one (1) Unit during the Unit program. Plan participants, who enrolled in the AMI at a minimum of $100 per month, received one hundred (100) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $250 per month, received two hundred and fifty (250) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $500 per month, received five hundred (500) ZNWAY warrants. The AMI program required 90 days of participation to receive the ZNWAY warrants. Existing AMI participants were entitled to participate in this monthly program by increasing their monthly amount above the minimum $50.00 per month.

 

The ZNWAV warrants became exercisable on March 31, 2023 and continued to be exercisable through June 28, 2023 at a per share exercise price of $0.05.

 

As of June 28, 2023, any outstanding ZNWAV warrants expired.

 

The ZNWAW warrants became exercisable on April 14, 2023 and continued to be exercisable through July 13, 2023 at a per share exercise price of $0.05.

 

As of July 13, 2023, any outstanding ZNWAW warrants expired.

 

The ZNWAX warrants became exercisable on May 2, 2023 and continued to be exercisable through July 31, 2023 at a per share exercise price of $0.05.

 

22

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

On July 31, 2023, any outstanding ZNWAX warrants expired.

 

The ZNWAY warrants became exercisable on June 12, 2023 and continued to be exercisable through September 10, 2023 at a per share exercise price of $0.05.

 

On September 10, 2023, any outstanding ZNWAY warrants expired.

 

Amendment No. 3 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under Amendment No. 3. This Unit Option period began on May 15, 2023 and terminated on June 15, 2023.

 

Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1 and Amendment No.2. Amendment No. 3 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. As mentioned above, this Unit Option began on May 15, 2023 and terminated on June 15, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional two hundred (200) shares of Common Stock at a per share exercise price of $0.25. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWAZ” and will not be registered for trading on the OTCQB or any other stock market or trading market.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional three hundred (300) warrants at an exercise price of $0.25 during this Unit Option Program. The three hundred (300) additional warrants were for enrolling into the AMI program and received the above warrant with the Company notation of “ZNWAZ.” Existing subscribers to the AMI were entitled to the additional three hundred (300) warrants, if they purchased at least one (1) Unit during the Unit program.

 

The ZNWAZ warrants became exercisable on July 17, 2023 and continue to be exercisable through July 17, 2024 at a per share exercise price of $0.25.

 

Amendment No. 4 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under our Unit Program with this Amendment No. 4. This Unit Option period began on November 6, 2023 and was scheduled to terminate on December 31, 2023. See Amendment No 5 below for data on an extension.

 

Our Unit Program consists of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 4 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option began on November 6, 2023 and terminated on December 31, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $0.25. The participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWBA” and will not be registered for trading on the OTCQB or any other stock market or trading market.

 

23

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and received the above warrant with the Company notation of “ZNWBA.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they purchased at least one (1) Unit during the Unit program.

 

The ZNWBA warrants became exercisable on January 15, 2024, and continue to be exercisable through January 15, 2025, unless extended, at a per share exercise price of $0.25. See Amendment No. 5 below for new dates.

 

Amendment No. 5 – Extension of Termination Date to January 31, 2024

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consisted of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended the Unit Program that was to terminate December 31, 2023, but now was scheduled to terminate on January 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on February 15, 2024, instead of January 15, 2024 and continue to be exercisable through February 15, 2025, instead of January 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.

 

The date of this Amendment No. 5 to Prospectus Supplement was December 20, 2023.

 

Amendment No. 6 – Extension of Termination Date to February 29, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended the Unit Program that was to terminate January 31, 2024, but now was scheduled to terminate February 29, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

24

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on March 15, 2024, instead of February 15, 2024 and continue to be exercisable through March 15, 2025, instead of February 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 6 to Prospectus Supplement was January 29, 2024.

 

Amendment No. 7 – Extension of Termination Date to March 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate February 29, 2024, but now will terminate March 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on April 15, 2024, instead of March 15, 2024 and continue to be exercisable through April 15, 2025, instead of March 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 7 to Prospectus Supplement was February 26, 2024.

 

25

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Amendment No. 8 – Extension of Termination Date to April 30, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate March 31, 2024, but now will terminate April 30, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on May 15, 2024, instead of April 15, 2024 and continue to be exercisable through May 15, 2025, instead of April 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 8 to Prospectus Supplement was March 23, 2024.

 

Amendment No. 9 – Extension of Termination Date to May 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate April 30, 2024, but now will terminate May 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on June15, 2024, instead of May 15, 2024 and continue to be exercisable through June 15, 2025, instead of May 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

26

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 9 to Prospectus Supplement was April 24, 2024.

 

For the three months ended March 31, 2024, and 2023, approximately $3,557,000 and $792,000 were raised under the DSPP program, respectively. The $3,557,000 figure was reduced by $816,000 in equity issuance costs to an outside party resulting in net cash provided of $2,741,000.

 

The company raised approximately $1,959,000 from the period April 1, 2024 through May 7, 2024, under the DSPP program.

 

The warrants represented by the company notation ZNWAA are tradeable on the OTCQB market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-Q, are not tradeable and are used internally for classification and accounting purposes only.

 

E. Subscription Rights Offering  

 

On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”

 

The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.

 

On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of June 29, 2023, any outstanding ZNWAI warrants expired.

 

Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.

 

The 2018 Subscription Rights Offering terminated on May 31, 2018. The Company raised net proceeds of approximately $3,038,000, from the subscription of Rights, after deducting fees and expenses of $243,000 incurred in connection with the rights offering.

 

27

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

F. Warrant Table  

 

The warrants balances at December 31, 2023 and transactions since January 1, 2024 are shown in the table below:

 

Warrants  Exercise
Price
   Warrant
Termination
Date
  Outstanding
Balance,
12/31/2023
   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding
Balance,
03/31/2024
 
ZNWAA  $2.00   01/31/2025   1,498,804    
-
    
-
    
-
    1,498,804 
ZNWAG  $1.00   01/08/2024   240,068    
-
    
-
    (240,068)   
-
 
ZNWAM  $0.05   12/31/2024   4,376,000    
-
    
-
    
-
    4,376,000 
ZNWAQ  $0.05   12/31/2024   23,428,348    
-
    
-
    
-
    23,428,348 
ZNWAZ  $0.25   07/17/2024   153,800         
-
    
-
    153,800 
Outstanding warrants           29,697,020    
            -
    
         -
    (240,068)   29,456,952 

 

28

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

G. Warrant Descriptions  

 

The price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those warrants with an expiration date beyond the balance sheet date.

 

 

 

      Period of Grant   US$     Expiration Date
ZNWAA Warrants   A,B,E,I   March 2013 – December 2014     2.00     January 31, 2025
ZNWAM Warrants   C,F,J,K   January 2021 – March 2021     0.05     December 31, 2024
ZNWAQ Warrants   C,F,J,K   June 2021     0.05     December 31, 2024
ZNWAS Warrants   D   August 2021 – March 2022     0.25     December 31, 2025
ZNWAT Warrants   D   August – September 2022     0.25     December 31, 2025
ZNWAU Warrants   D   October – November 2022     0.25     December 31, 2025
ZNWAZ Warrants   G   May – June 2023     .25     July 17, 2024
ZNWBA Warrants   H   November – December 2023     .25     June 15, 2025 

 

A On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year.
   
B On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years.
   
C On March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023.
   
D These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025.
   
E On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year.
   
F The warrant exercise price was lowered to $0.05 on December 28, 2022.
   
G On May 15, 2023, the Company announced a new Unit Offering and the related ZNWAZ warrant. 

 

H On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant.

 

I On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year.

 

J On December 18, 2023, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to March 31, 2024.

 

K On March 23, 2024, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to December 31, 2024.

 

29

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 4 - Unproved Oil and Gas Properties, Full Cost Method 

 

Unproved oil and gas properties, under the full cost method, are comprised as follows:

 

   March 31,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   2,592    2,538 
Capitalized salary costs   2,470    2,444 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   10,424    10,198 
Other costs   39    39 
    16,943    16,637 

 

Post-impairment of unproved oil and gas properties comprised as follows: 

 

   For the three months ended
March 31,
 
   2024   2023 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   
        -
    11 
Capitalized salary costs   
-
    
-
 
Capitalized interest costs   
-
    
-
 
Legal and seismic costs, license fees and other preparation costs   
-
    34 
    
-
    45 

 

 

Changes in Unproved oil and gas properties during the three months ended March 31, 2024 and 2023 are as follows:

 

   March 31,
2024
   March 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:          
Drilling costs, and other operational related costs   54    63 
Capitalized salary costs   26    26 
Capitalized interest costs   
-
    
-
 
Legal and seismic costs, license fees and other preparation costs   226    124 
Other costs   
-
    
-
 
Impairment of unproved oil and gas properties   
-
    (45)
    *306   *168

 

* Inclusive of non-cash amounts of approximately $664,000, and $1,515,000 during the three months ended March 31, 2024, and 2023, respectively

 

Please refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.

 

30

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 5 - Right of use lease assets and lease obligations  

 

The Company is a lessee in several non-cancellable operating leases for transportation and office space.

 

The table below presents the operating lease assets and liabilities recognized on the balance sheets as of March 31, 2024 and December 31, 2023: 

 

   March 31,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Operating lease assets  $956   $194 
           
Operating lease liabilities:          
Current operating lease liabilities  $224   $167 
Non-current operating lease liabilities  $708   $24 
Total operating lease liabilities  $932   $191 

 

The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.

 

The Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date.

 

The Company’s field office in Caesarea, Israel is under lease for 6,566 square feet.

 

The Company had an option to renew the lease for another five years from February 1, 2024 to January 31, 2029, provided it is not in breach of the agreement, where it is required as well to furnish a notice of intent to exercise the option six months prior to termination of lease, and it furnishes a bank guarantee and insurance confirmation prior to commencement of the option period. The Company exercised the option to renew the lease for another seven years from February 1, 2024 through January 31, 2031, when rent is to be paid on a monthly basis in the base amount of approximately NIS 46,500 per month (approximately $12,800) at the exchange rate in effect on the date of this report and is linked to an increase (but not a decrease) in the CPI.

 

The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of March 31, 2024 are:

 

   March 31,
2024
 
Weighted average remaining lease term (years)   6.00 
Weighted average discount rate   7.62%

 

31

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 5 - Right of use lease assets and leases obligations (cont’d)

 

The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of March 31, 2024:

 

   US$
thousands
 
2024   281 
2025   156 
2026   155 
2027   150 
2028   150 
Thereafter   275 
Total undiscounted future minimum lease payments   1,167 
Less: portion representing imputed interest   (235)
Total undiscounted future minimum lease payments   932 

 

Operating lease costs were $75,000 and $69,000 for the three months ended March 31, 2024, and 2023, respectively. Operating lease costs are included within general and administrative expenses on the statements of operations.

 

Cash paid for amounts included in the measurement of operating lease liabilities was $88,000 and $70,000 for the three months ended March 31, 2024, and 2023, respectively, and this amount is included in operating activities in the statements of cash flows.

 

Right-of-use assets obtained in exchange for new operating lease liabilities were $829 and $nil for the three months ended March 31, 2024, and 2023, respectively.

 

32

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 6 - Commitments and Contingencies

 

A. Litigation  

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. 

 

The Company is not subject to any litigation at the present time. 

 

B. Market Conditions – Coronavirus, Israel-Hamas War and Russia-Ukraine War 

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.

 

On October 7, 2023, Hamas, a militant terrorist organization in Gaza, infiltrated southern Israel, killing and injuring at least one thousand Israeli citizens. Roughly 250 Israeli hostages were then taken back to Gaza. This unprovoked attack led the nation of Israel to declare war on Hamas approximately one week later. As of the date of this report, Israel remains at war and there are daily battles inside the Gaza strip. Israel’s stated goals are to completely dismantle the terror infrastructure of Gaza, including its extensive tunnel network and to bring back safely all of the hostages.

 

There is uncertainty as to how long the war inside the Gaza strip will last and whether the war will expand to other hostile parties in the region. While we acknowledge that uncertainty and its potential adverse effects on Zion’s business, the Company is moving forward with its planning and logistics activities. We are working with our international service providers on projected availability timelines and other details. All of these key vendors have expressed willingness to assist Zion in its exploration activities. It is important to note that Zion’s license area is not located near any current combat zones.

 

Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although the Russian war against Ukraine did not have a material adverse impact on the Company’s financial results for the quarter ended March 31, 2024, at this time the Company is unable to fully assess the aggregate impact the Russian war against Ukraine will have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the global economy, future energy pricing, its impact to the businesses of the Company’s, and actions that may be taken by governmental authorities related to the war.

 

C. Environmental and Onshore Licensing Regulatory Matters  

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous Zion filings.

 

The Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to obtain all of the necessary authorizations and approvals to drill and production test exploration wells.

 

As of March 31, 2024, and December 31, 2023, the Company accrued $nil and $nil for license regulatory matters.

 

33

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 6 - Commitments and Contingencies (cont’d)

 

D. Insurance Financing 

 

Effective November 16, 2023, the Company renewed its third-party liability (“TPL”) insurance policy in Israel with total premiums, taxes and fees for $76,263. A cash down payment of $22,699 was paid on November 16, 2023. Under the terms of the insurance financing, payments of $5,356, which include interest at the rate of 13.99% per annum, are due each month for 10 months commencing on December 16, 2023.

 

Effective December 28, 2023, the Company renewed its D&O insurance policy with total premiums, taxes and fees for $441,598. A cash down payment of $68,733 was paid on December 13, 2023. Under the terms of the insurance financing, payments of $37,287, which include interest at the rate of 13.4% per annum, are due each month for 10 months commencing on January 28, 2024.

 

Effective March 12, 2024, 2024, the Company renewed its rig insurance policy with total premiums, taxes and fees for $94,989. A cash down payment of $37,637 was paid on February 23, 2024. Under the terms of the insurance financing, payments of $9,499, which include interest at the rate of 13.99% per annum, are due each month for 10 months commencing on April 12, 2024.

 

As of March 31, 2024 and 2023, the Company had contractual obligations to pay for various lines of insurance, including directors and officers, rig and third-party liability. The balances for insurance financing were $388,000 and $432,000, respectively. 

 

We haven’t experienced any resistance from our insurance carriers as a result of the Israel-Hamas war, but we acknowledge the uncertainty the war creates in that respect.

 

E. Bank Guarantees  

 

As of March 31, 2024, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $944,000) and others (approximately $87,000) with respect to its drilling operation in an aggregate amount of approximately $1,031,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits – restricted.

 

F. Vendor Concentration 

 

The Company’s financial instruments that are exposed to a concentration of credit risk are accounts payable. At March 31, 2024, there were four suppliers that represent 10% or more of the Company’s accounts payable balance. At December 31, 2023, there were three suppliers that represent 10% or more of the Company’s accounts payable balance.

 

G. Risks 

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2024 through March 31, 2024, the USD has fluctuated by approximately 1.5% against the NIS (the USD strengthened relative to the NIS). Also, during the period January 1, 2023 through December 31, 2023, the USD fluctuated by approximately 3.1% against the NIS (the USD strengthened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2024, we had cash, cash equivalents and short-term bank deposits of approximately $2,146,000. The weighted average annual interest rate related to our cash and cash equivalents for the three months ended March 31, 2024, exclusive of funds at US banks that earn no interest, was approximately 3.20%.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

 

Note 7 - Subsequent Events

 

  (i) Approximately $1,959,000 was collected through the Company’s DSPP program during the period April 1 through May 7, 2024 .

 

34

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

THE FOLLOWING DISCUSSION SHOULD BE READ IN CONJUNCTION WITH OUR UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND THE RELATED NOTES TO THOSE STATEMENTS INCLUDED IN THIS FORM 10-Q. SOME OF OUR DISCUSSION IS FORWARD-LOOKING AND INVOLVES RISKS AND UNCERTAINTIES. FOR INFORMATION REGARDING RISK FACTORS THAT COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS, REFER TO THE DISCUSSION OF RISK FACTORS IN THE “DESCRIPTION OF BUSINESS” SECTION OF OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2023, FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.

 

Forward-Looking Statements

 

Certain statements made in this discussion are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may materially differ from actual results.

 

Forward-looking statements can be identified by terminology such as “may”, “should”, “expects”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, or “continue” or the negative of these terms or other comparable terminology and include, without limitation, statements regarding: 

 

  The Israel-Hamas war which began in October 2023 and its effect on our exploration program;
     
  The going concern qualification in our consolidated condensed financial statements;
     
  Our ability to obtain new license areas to continue our exploration program;

 

  our liquidity and our ability to raise capital to finance our overall exploration and development activities within our license area;

 

  our ability to continue meeting the requisite continued listing requirements by OTCQB;

 

  interruptions, increased financial costs and other adverse impacts of the covid 19 coronavirus pandemic, the Israel-Hamas war and the Russia-Ukraine war on the drilling and testing of our petroleum exploration program and our capital raising efforts;

 

  our ability to explore for and develop natural gas and oil resources successfully and economically within a license area;

 

  our ability to maintain the exploration license rights to continue our petroleum exploration program;

 

  the availability of equipment, such as seismic equipment, drilling rigs, and production equipment as well as access to qualified personnel;

 

  the impact of governmental regulations, permitting and other legal requirements in Israel relating to onshore exploratory drilling;

 

  our estimates of the time frame within which future exploratory activities will be undertaken;

 

  changes in our exploration plans and related budgets;

 

  the quality of future license areas with regard to, among other things, the existence of reserves in economic quantities;

 

35

 

 

  anticipated trends in our business;

 

  our future results of operations;

 

  our capital expenditure program;

 

  future market conditions in the oil and gas industry

 

  the demand for oil and natural gas, both locally in Israel and globally; and

 

  the impact of fluctuating oil and gas prices on our exploration efforts

 

All references in this Quarterly Report to the “Company”, “Zion”, “we”, “us”, or “our”, are to Zion Oil and Gas, Inc., a Delaware corporation, and its wholly-owned subsidiaries, Zion Drilling, Inc. and Zion Drilling Services, Inc. described below.

 

Current Exploration and Operation Efforts 

 

Zion Oil and Gas, Inc., a Delaware corporation, is an oil and gas exploration company with a history of 24 years of oil and gas exploration in Israel. We were incorporated in Florida on April 6, 2000 and reincorporated in Delaware on July 9, 2003. We completed our initial public offering in January 2007. Our common stock, par value $0.01 per share (the “Common Stock”) currently trades on the OTCQB marketplace of OTC Markets, Inc. under the symbol “ZNOG” and our Common Stock warrant under the symbol “ZNOGW.” On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.

 

On September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil and gas exploration on approximately 75,000 acres or 302 square kilometers. This Exploration License 434 is valid for three years until September 13, 2026 with four potential 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes our previous NML 428.

   

We continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum system with significant exploration potential. As previously announced, Zion is deploying new technologies and stimulation methods for its planned re-entry into the MJ-01 well with the objective of potentially unlocking hydrocarbon flows in several identified key zones. Zion has begun tendering service contractors and ancillary items required for efficient operations.

 

36

 

 

On February 21, 2024, members of the Supervisory Committee visited our rig site. During this visit, they interacted with staff from Zion Oil & Gas, and our consultants and potential service providers. Some of these interactions occurred at Kibbutz Sde Eliyahu, while others were conducted through video conferencing with participants from the United States, Europe and the Middle East. Following these discussions, the Committee has officially accepted our work plan for the MJ-01 project. This acceptance allows us to sign agreements and secure mobilization dates with our service providers required to commence and complete the project.

 

We have begun working on visa applications for our rig crew in preparation for their entry into Israel. Upon the completion of the work visa process, the crew will travel to Israel and begin inspecting the rig to make sure it conforms to industry requirements for workover operations. Afterwards, the crew will rig down, slide the drilling rig over several meters and rig up on the MJ-01 well location. The crew will then open the well and continue to follow the approved work plan in conjunction with the selected service providers. This should occur toward the end of Q2 or early Q3 depending on subsurface conditions encountered during the reopening phase and contractor scheduling availability.

 

We have made strategic adjustments to control both cost and time. Despite the typical delays during Passover, which this year began on the evening of April 22nd and ended on the evening of April 30th, we have satisfied all regulatory requirements necessary to commence operations, including, as previously mentioned, approval by the Supervisory Committee. We are ready and moving forward.

 

I-35 Drilling Rig & Associated Equipment

 

    Three-month period ended March 31, 2024  
    I-35
Drilling Rig
    Rig
Spare Parts
    Other
Drilling Assets
    Total  
    US$ thousands     US$ thousands     US$ thousands     US$ thousands  
December 31, 2023     4,591       608       311       5,510  
Asset Additions     -       -       -       -  
Asset Depreciation     (159 )     -       (32 )     (191 )
Asset Disposals for Self-Consumption     -       -       -       -  
March 31, 2024     4,432       608       279       5,319  

 

Zion’s ability to fully undertake all of these aforementioned activities is subject to its raising the needed capital from its continuing offerings, of which no assurance can be provided.

 

37

 

 

 

Map 1. Zion’s New Megiddo Valleys 434 License as of March 31, 2024.

 

38

 

 

Onshore Licensing, Oil and Gas Exploration and Environmental Guidelines 

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental cleanup of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner, the Energy Ministry, and the Environmental Ministry in recent years as it pertains to oil and gas activities. Mention of these guidelines was included in previous Zion Oil & Gas filings.

 

We acknowledge that these new regulations are likely to increase the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that additional financial burdens could occur as a result of the Ministry requiring cash reserves that could otherwise be used for operational purposes. 

 

Capital Resources Highlights 

 

We need to raise significant funds to finance the continued exploration efforts and maintain orderly operations. To date, we have funded our operations through the issuance of our securities and convertible debt. We will need to continue to raise funds through the issuance of equity and/or debt securities (or securities convertible into or exchangeable for equity securities). No assurance can be provided that we will be successful in raising the needed capital on terms favorable to us (or at all).

 

The Dividend Reinvestment and Stock Purchase Plan

 

On March 13, 2014, Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three-year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration Statement on Form S-3, as thereafter amended.

 

Please see Footnote 3D (“Dividend Reinvestment and Stock Purchase Plan (“DSPP”)), which is a part of this Form 10-Q filing, for details about specific stock purchase and unit programs, dates, and filings during the years 2023 and 2024.

 

For the three months ended March 31, 2024, and 2023, approximately $3,557,000, and $792,000 were raised under the DSPP program, respectively. The $3,557,000 figure was reduced by $816,000 in equity issuance costs to an outside party resulting in net cash provided of $2,741,000.

 

39

 

 

The warrants balances at December 31, 2023 and transactions since January 1, 2024 are shown in the table below:

 

Warrants  Exercise
Price
   Warrant
Termination
Date
  Outstanding
Balance,
12/31/2023
   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding
Balance,
03/31/2024
 
ZNWAA  $2.00   01/31/2025   1,498,804    -    -    -    1,498,804 
ZNWAG  $1.00   01/08/2024   240,068    -    -    (240,068)   - 
ZNWAM  $0.05   12/31/2024   4,376,000    -    -    -    4,376,000 
ZNWAQ  $0.05   12/31/2024   23,428,348    -    -    -    23,428,348 
ZNWAZ  $0.25   07/17/2024   153,800    -    -    -    153,800 
Outstanding warrants           29,697,020           -           -    (240,068)   29,456,952 

 

Principal Components of our Cost Structure  

 

Our operating and other expenses primarily consist of the following:

 

Impairment of Unproved Oil and Gas Properties: Impairment expense is recognized if a determination is made that a well will not be commercially productive. The amounts include amounts paid in respect of the drilling operations as well as geological and geophysical costs and various amounts that were paid to Israeli regulatory authorities.

 

General and Administrative Expenses: Overhead, including payroll and benefits for our corporate staff, costs of managing our exploratory operations, audit and other professional fees, and legal compliance is included in general and administrative expenses. General and administrative expenses also include non-cash stock-based compensation expense, investor relations related expenses, lease and insurance and related expenses.

 

Depreciation, Depletion, Amortization and Accretion: The systematic expensing of the capital costs incurred to explore for natural gas and oil represents a principal component of our cost structure. As a full cost company, we capitalize all costs associated with our exploration, and apportion these costs to each unit of production, if any, through depreciation, depletion and amortization expense. As we have yet to have production, the costs of abandoned wells are written off immediately versus being included in this amortization pool.

 

Going Concern Basis

 

Since we have limited capital resources, no revenue to date and a loss from operations, our consolidated condensed financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. The appropriateness of using the going concern basis is dependent upon our ability to obtain additional financing or equity capital and, ultimately, to achieve profitable operations. Therefore, there is substantial doubt about our ability to continue as a going concern for one year from the date the financials were issued. The consolidated condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Israel-Hamas War 

 

On October 7, 2023, Hamas, a militant terrorist organization in Gaza, infiltrated southern Israel, killing and injuring at least one thousand Israeli citizens. Roughly 250 Israeli hostages were then taken back to Gaza. This unprovoked attack led the nation of Israel to declare war on Hamas approximately one week later. As of the date of this report, Israel remains at war and there are daily battles inside the Gaza strip. Israel’s stated goals are to completely dismantle the terror infrastructure of Gaza, including its extensive tunnel network and to bring back safely all of the hostages.

 

There is uncertainty as to how long the war inside the Gaza strip will last and whether the war will expand to other hostile parties in the region. While we acknowledge that uncertainty and its potential adverse effects on Zion’s business, the Company is moving forward with its planning and logistics activities. We are working with our international service providers on projected availability timelines and other details. All of these key vendors have expressed willingness to assist Zion in its exploration activities. It is important to note that Zion’s license area is not located near any current combat zones.

 

Russia – Ukraine War

 

Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although the Russian war against Ukraine did not have a material adverse impact on the Company’s financial results for the year ended December 31, 2023, at this time the Company is unable to fully assess the aggregate impact the Russian war against Ukraine will have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the global economy, future energy pricing, its impact to the businesses of the Company’s, and actions that may be taken by governmental authorities related to the war.

 

40

 

 

Critical Accounting Policies  

 

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated condensed financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenues and expense during the reporting period.

 

We have identified the accounting principles which we believe are most critical to the reported financial status by considering accounting policies that involve the most complex of subjective decisions or assessment.

 

Impairment of Oil and Gas Properties 

 

We follow the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in income from continuing operations before income taxes, and the adjusted carrying amount of the unproved properties is amortized on the unit-of-production method.

 

Our oil and gas properties represent an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. A further impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

Abandonment of properties is accounted for as adjustments to capitalized costs. The net capitalized costs are subject to a “ceiling test” which limits such costs to the aggregate of the estimated present value of future net revenues from proved reserves discounted at ten percent based on current economic and operating conditions, plus the lower of cost or fair market value of unproved properties. The recoverability of amounts capitalized for oil and gas properties is dependent upon the identification of economically recoverable reserves, together with obtaining the necessary financing to exploit such reserves and the achievement of profitable operations.

 

During the three months ended March 31, 2024, and 2023, respectively, the Company recorded nil and $45,000 post-impairment charges.

 

The total net book value of our unproved oil and gas properties under the full cost method is $16,943,000 and $16,637,000 at March 31, 2024 and at December 31, 2023, respectively.

 

Asset Retirement Obligation

 

We record a liability for asset retirement obligation at fair value in the period in which it is incurred and a corresponding increase in the carrying amount of the related long-lived assets.

 

Fair Value Considerations

 

We follow ASC 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

There are three levels of inputs to fair value measurements - Level 1, meaning the use of quoted prices for identical instruments in active markets; Level 2, meaning the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; and Level 3, meaning the use of unobservable inputs. We use Level 1 inputs for fair value measurements whenever there is an active market, with actual quotes, market prices, and observable inputs on the measurement date. We use Level 2 inputs for fair value measurements whenever there are quoted prices for similar securities in an active market or quoted prices for identical securities in an inactive market. We use observable market data whenever available.

 

41

 

 

RESULTS OF OPERATIONS    

 

   For the three months ended
March 31,
 
   2024   2023 
   (US $ in thousands) 
Operating costs and expenses:        
General and administrative expenses   1,175    1,503 
Other   599    583 
Impairment of unproved oil and gas properties   -    45 
Subtotal Operating costs and expenses   1,774    2,131 
           
Other (income) expense, net   (12)   8 
Net loss   1,762    2,139 

 

Revenue. We currently have no revenue generating operations.

 

Operating costs and expenses. Operating costs and expenses for the three months ended March 31, 2024 were $1,774,000 compared to $2,131,000 for the three months ended March 31, 2023.

 

General and administrative expenses. General and administrative expenses for the three months ended March 31, 2024 were $1,175,000, compared to $1,503,000 for the three months ended March 31, 2023. This is a variance of $328,000 or 28%. The decrease in General and administrative expenses during the three months ended March 31, 2024 is primarily attributable to lower non-cash expenses recorded in connection with stock option grants.

 

Other expense. Other expense during the three months ended March 31, 2024 was $599,000 compared to $583,000 for the three months ended March 31, 2023. This is a variance of $16,000 or 3%. Other general and administrative expenses are comprised of non-compensation and non-professional expenses incurred. The increase in other expenses is an immaterial difference compared to 2023.

 

Impairment of unproved oil and gas properties. Impairment of unproved oil and gas properties expenses during the three months ended March 31, 2024 was nil compared to $45,000 for the three months ended March 31, 2023. The expenses recorded in 2023 are post impairment charges to the impairment recorded during 2022 related to the MJ-2 well.

 

Other (income) expense, net. Other (income) expense, net for the three months ended March 31, 2024 was ($12,000), compared to $8,000 for the three months ended March 31, 2023. This is a variance of $20,000 or 167%. The decrease in these expenses in 2024 is primarily attributable to exchange rate of the NIS fluctuations to the USD.

 

Net Loss. Net loss for the three months ended March 31, 2024 was $1,762,000 compared to $2,139,000 for the three months ended March 31, 2023. This is a variance of $377,000 or 21%. The primary driver of the lower net loss in 2024 compared to 2023 is the lower non-cash expenses recorded in connection with stock option grants in 2024.

 

42

 

 

Liquidity and Capital Resources 

 

Liquidity is a measure of a company’s ability to meet potential cash requirements. As discussed above, we have historically met our capital requirements through the issuance of common stock as well as proceeds from the exercise of warrants and options to purchase common shares.

 

Our ability to continue as a going concern is dependent upon obtaining the necessary financing to complete further exploration and development activities and generate profitable operations from our oil and natural gas interests in the future. Our current operations are dependent upon the adequacy of our current assets to meet our current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, our ability to continue as a going concern will be impaired. Our financial statements for the three months ended March 31, 2024 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We have incurred a history of operating losses and negative cash flows from operations. Therefore, there is substantial doubt about our ability to continue as a going concern for one year from the date the financials were issued.

 

At March 31, 2024, we had approximately $1,115,000 in cash and cash equivalents compared to $615,000 at December 31, 2023, which does not include any restricted funds. Our working capital (current assets minus current liabilities) was $559,000 at March 31, 2024 and ($349,000) at December 31, 2023.

 

As of March 31, 2024, we provided bank guarantees to various governmental bodies (approximately $944,000) and others (approximately $87,000) in respect of our drilling operation in the aggregate amount of approximately $1,031,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits restricted.

 

During the three months ended March 31, 2024, and 2023, cash used in operating activities totaled $2,003,000, and $917,000, respectively. Cash provided by financing activities during the three months ended March 31, 2024, and 2023, was $2,838,000, and $800,000, respectively, and is primarily attributable to proceeds received from the Dividend Reinvestment and Stock Purchase Plan (the “DSPP” or “Plan”). Net cash used in investing activities such as unproved oil and gas properties, equipment and spare parts was $324,000 and $838,000 for the three months ended March 31, 2024, and 2023, respectively.

 

Accounting standards require management to evaluate our ability to continue as a going concern for a period of one year subsequent to the date of the filing of this Form 10-Q. We expect to incur additional significant expenditures to further our exploration and development programs. While we raised approximately $1,959,000 during  the period April 1, 2024 through May 7, 2024, we will need to raise additional funds in order to continue our exploration and development activities in our license area. Additionally, we estimate that, when we are not actively drilling a well, our expenditures are approximately $600,000 per month excluding exploratory operational activities. However, when we are actively drilling a well, we estimate an additional minimum expenditure of approximately $2,500,000 per month. The above estimates are subject to change. Subject to the qualifications specified below, management believes that our existing cash balance, coupled with anticipated proceeds under the DSPP, will be sufficient to finance our plan of operations through July 2024.

 

The outbreak of the coronavirus has to date significantly disrupted business operations and resulted in significantly increased unemployment in the general economy. The extent to which the coronavirus impacts our operations, specifically our capital raising efforts, as well as our ability to continue our exploratory efforts, will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others.

 

Similar uncertainties are posed by the Israel Hamas war and its duration and whether the war expands regionally to include other hostile parties. It is important to note that Zion’s license area is not located near any current combat zone.

 

No assurance can be provided that we will be able to raise the needed operating capital.

 

Even if we raise the needed funds, there are factors that can nevertheless adversely impact our ability to fund our operating needs, including (without limitation), the potential impact of the Israel-Hamas war, unexpected or unforeseen cost overruns in planned non-drilling exploratory work in existing license areas, the costs associated with extended delays in undertaking the required exploratory work, and plugging and abandonment activities which is typical of what we have experienced in the past. 

 

The financial information contained in these consolidated condensed financial statements has been prepared on a basis that assumes that we will continue as a going concern for one year from the date the financials were issued, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. This financial information and these consolidated condensed financial statements do not include any adjustments that may result from the outcome of this uncertainty. 

 

43

 

 

Off-Balance Sheet Arrangements

 

We do not currently use any off-balance sheet arrangements to enhance our liquidity or capital resource position, or for any other purpose.

 

Recently Issued Accounting Pronouncements

 

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2024 had a significant impact on our financial position, results of operations, or cash flow.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2024 through March 31, 2024, the USD has fluctuated by approximately 1.5% against the NIS (the USD strengthened relative to the NIS). Also, during the period January 1, 2023 through December 31, 2023, the USD fluctuated by approximately 3.1% against the NIS (the USD strengthened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2024 we had cash, cash equivalents and short-term and long-term bank deposits of approximately $2,146,000. The weighted average annual interest rate related to our cash and cash equivalents for the three months ended March 31, 2024, exclusive of funds at US banks that earn no interest, was approximately 3.20%.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

 

ITEM 4. CONTROLS AND PROCEDURES 

 

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms. As of March 31, 2024, our chief executive officer and our chief financial officer conducted an evaluation of the effectiveness of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and our chief financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2024.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in internal controls over financial reporting that occurred during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

44

 

 

PART II—OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS 

  

Litigation

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. 

 

The Company is not subject to any litigation at the present time. 

 

ITEM 1A. RISK FACTORS 

 

During the quarter ended March 31, 2024, there were no material changes to the risk factors previously reported in our Annual Report on Form 10-K for the year ended December 31, 2023. 

 

ITEM 2. UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None.

 

ITEM 5. OTHER INFORMATION:

 

None.

 

45

 

 

ITEM 6. EXHIBITS

 

Exhibit Index:

 

31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 under the Exchange Act
     
31.2   Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 under the Exchange Act
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished only)
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished only)
     
101.INS   XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

46

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

ZION OIL & GAS, INC.    
(Registrant)    
     
By: /s/ Robert W.A. Dunn   By: /s/ Michael B. Croswell Jr.
  Robert W. A. Dunn     Michael B. Croswell Jr.
  Chief Executive Officer     Chief Financial Officer
  (Principal Executive Officer)     (Principal Financial and Accounting Officer)
         
Date: May 8, 2024   Date:

May 8, 2024

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

 

Signature   Title   Date
         
/s/ Robert W.A. Dunn   Chief Executive Officer and Director,   May 8, 2024
Robert W.A. Dunn   (Principal Executive Officer)    
         
/s/ Michael B. Croswell Jr.   Chief Financial Officer   May 8, 2024
Michael B. Croswell Jr.   (Principal Financial and Principal Accounting Officer)    
         
/s/ William H. Avery   President and General Counsel   May 8, 2024
William H. Avery        
         
/s/ Martin M. van Brauman   EVP, Corporate Secretary, Treasurer and Director   May 8, 2024
Martin M. van Brauman        
         
/s/ John M. Brown   Chairman of the Board of Directors   May 8, 2024
John M. Brown        
         
/s/ Paul Oroian   Director   May 8, 2024
Paul Oroian        
         
/s/ John Seery   Director   May 8, 2024
John Seery        
         
/s/ Kent Siegel   Director   May 8, 2024
Kent Siegel        
         
/s/ Gene Scammahorn   Director   May 8, 2024
Gene Scammahorn        
         
/s/ Virginia Prodan   Director   May 8, 2024
Virginia Prodan        
         
/s/ Pandji Putra   Director   May 8, 2024
Pandji Putra        
         
/s/ Sarah Caygill   Director   May 8, 2024
Sarah Caygill        
         
/s/ Jeffrey Moskowitz   Director   May 8, 2024
Jeffrey Moskowitz        
         
/s/ Brad Dacus   Director   May 8, 2024
Brad Dacus        
         
/s/ Javier Mazon   Director   May 8, 2024
Javier Mazon        

 

47

 

NONE 0.00 0.00 531023 667023 50 P10M P10M P10M false --12-31 Q1 0001131312 001-33228 0001131312 2024-01-01 2024-03-31 0001131312 2024-05-06 0001131312 2024-03-31 0001131312 2023-12-31 0001131312 2023-01-01 2023-03-31 0001131312 us-gaap:CommonStockMember 2023-12-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001131312 us-gaap:RetainedEarningsMember 2023-12-31 0001131312 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001131312 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001131312 us-gaap:CommonStockMember 2024-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001131312 us-gaap:RetainedEarningsMember 2024-03-31 0001131312 us-gaap:CommonStockMember 2022-12-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001131312 us-gaap:RetainedEarningsMember 2022-12-31 0001131312 2022-12-31 0001131312 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001131312 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001131312 us-gaap:CommonStockMember 2023-03-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001131312 us-gaap:RetainedEarningsMember 2023-03-31 0001131312 2023-03-31 0001131312 znogw:NewMegiddoValleysLicenseMember 2023-09-14 0001131312 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001131312 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001131312 2023-01-01 2023-12-31 0001131312 znogw:I35DrillingRigMember 2023-12-31 0001131312 znogw:RigSparePartsMember 2023-12-31 0001131312 znogw:OtherDrillingAssetsMember 2023-12-31 0001131312 znogw:I35DrillingRigMember 2024-01-01 2024-03-31 0001131312 znogw:RigSparePartsMember 2024-01-01 2024-03-31 0001131312 znogw:OtherDrillingAssetsMember 2024-01-01 2024-03-31 0001131312 znogw:I35DrillingRigMember 2024-03-31 0001131312 znogw:RigSparePartsMember 2024-03-31 0001131312 znogw:OtherDrillingAssetsMember 2024-03-31 0001131312 srt:MinimumMember 2023-06-07 0001131312 srt:MaximumMember 2023-06-07 0001131312 znogw:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2021-06-09 0001131312 znogw:FourSeniorOfficersAndNineStaffMember 2024-01-01 2024-03-31 0001131312 znogw:TwoZeroTwoOneOmnibusIncentiveStockOptionPlanMember 2021-06-01 2021-06-09 0001131312 znogw:FourSeniorOfficersAndNineStaffMember 2024-03-31 0001131312 znogw:FiveStaffMembersAndOneSeniorOfficerMember 2024-01-01 2024-03-31 0001131312 znogw:OneStaffMember znogw:TwoZeroTwoOneEquityOmnibusPlanMember 2024-01-01 2024-03-31 0001131312 znogw:OneSeniorOfficersMember 2024-01-01 2024-03-31 0001131312 znogw:OneSeniorOfficersMember 2024-03-31 0001131312 znogw:OneBoardMember 2024-01-01 2024-03-31 0001131312 znogw:OneBoardMember znogw:TwoZeroTwoOneEquityOmnibusPlanMember 2024-01-01 2024-03-31 0001131312 znogw:FiveSeniorOfficersAndOneStaffMember 2023-01-01 2023-03-31 0001131312 znogw:FiveSeniorOfficersAndOneStaffMember 2023-03-31 0001131312 znogw:FiveSeniorOfficersAndOneStaffMember 2024-01-01 2024-03-31 0001131312 znogw:OneStaffMember znogw:TwoZeroTwoOneEquityOmnibusPlanMember 2023-01-01 2023-03-31 0001131312 znogw:OneStaffMember 2023-03-31 0001131312 znogw:OneSeniorOfficersMember 2023-01-01 2023-03-31 0001131312 us-gaap:WarrantMember 2020-09-15 2020-09-15 0001131312 znogw:ZNWAEWarrantsMember 2020-09-15 2020-09-15 0001131312 znogw:ZNWAFWarrantMember 2020-09-15 2020-09-15 0001131312 znogw:ZnwajWarrantsMember 2022-12-14 2022-12-14 0001131312 znogw:ZNWAGMember 2022-12-14 2022-12-14 0001131312 znogw:ZNWAHMember 2020-09-15 2020-09-15 0001131312 znogw:ZNWAHWarrantsMember 2020-09-15 2020-09-15 0001131312 znogw:ZnwajWarrantsMember 2020-09-15 2020-09-15 0001131312 2020-09-15 2020-09-15 0001131312 us-gaap:WarrantMember us-gaap:CommonStockMember 2024-03-31 0001131312 znogw:ZNWAMWarrantMember 2022-03-21 2022-03-21 0001131312 znogw:ZNWAMWarrantMember 2022-03-21 0001131312 znogw:ZNWAEWarrantsMember 2023-05-16 0001131312 2023-06-12 0001131312 znogw:ZNWAMWarrantMember 2024-03-31 0001131312 2022-06-02 0001131312 znogw:ZnwapWarrantMember 2022-03-21 2022-03-21 0001131312 2022-01-01 2022-06-30 0001131312 znogw:ZNWAOMember 2024-03-31 0001131312 znogw:ZNWAOMember 2023-07-15 0001131312 2023-06-16 2023-06-16 0001131312 us-gaap:WarrantMember 2023-08-21 2023-08-21 0001131312 znogw:WarrantOneMember 2023-10-19 2023-10-19 0001131312 znogw:WarrantTwoMember 2023-12-18 2023-12-18 0001131312 us-gaap:WarrantMember 2024-03-28 2024-03-28 0001131312 znogw:ZnwarWarrantMember 2024-03-31 0001131312 znogw:ZnwarWarrantMember 2022-06-22 0001131312 znogw:ZnwarWarrantMember 2021-01-01 2021-12-31 0001131312 2022-03-21 2022-03-21 0001131312 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001131312 exch:OTCB 2024-03-31 0001131312 znogw:ZNWAUWarrantsMember us-gaap:CommonStockMember 2024-03-31 0001131312 znogw:ZionMember 2023-08-31 2023-08-31 0001131312 srt:MinimumMember znogw:ZionMember 2023-01-01 2023-12-31 0001131312 znogw:ZionMember 2024-01-01 2024-03-31 0001131312 us-gaap:SubsequentEventMember 2024-04-01 2024-04-01 0001131312 srt:MaximumMember 2024-03-31 0001131312 srt:MinimumMember 2023-12-31 0001131312 znogw:OTCQXWarrantsMember 2024-01-01 2024-03-31 0001131312 znogw:OTCQXWarrantsMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001131312 znogw:OTCQXWarrantsMember 2024-03-31 0001131312 znogw:ZNWAVWarrantsMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAVWarrantsMember 2024-03-31 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAYMember 2024-03-31 0001131312 srt:MinimumMember znogw:ZNWAYMember 2024-01-01 2024-03-31 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:ZNWAYMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAYWarrantsMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAYMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAVWarrantsMember 2023-06-28 0001131312 znogw:ZNWAWWarrantsMember 2023-07-13 0001131312 znogw:ZNWAXWarrantsMember 2023-07-31 0001131312 znogw:ZNWAYMember 2023-09-10 0001131312 us-gaap:WarrantMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001131312 znogw:ZnwakWarrantsMember 2024-03-31 0001131312 znogw:ZNWAZWarrantsMember 2024-03-31 0001131312 us-gaap:WarrantMember 2024-03-31 0001131312 znogw:ZNWAZWarrantsMember 2023-07-17 0001131312 znogw:UnitOptionProgramMember 2024-03-31 0001131312 znogw:ZNWAZWarrantsMember us-gaap:CommonStockMember 2024-03-31 0001131312 znogw:ZNWBAWarrantsMember 2024-03-31 0001131312 znogw:AutomaticMonthlyInvestmentsMember 2024-03-31 0001131312 znogw:ZNWBAWarrantsMember us-gaap:WarrantMember 2024-03-31 0001131312 znogw:UnitOptionMember 2024-03-31 0001131312 znogw:ZNWBAWarrantsMember znogw:ExtensionOfTerminationDateToJanuary312024Member 2024-03-31 0001131312 znogw:ZNWBAWarrantsMember 2024-01-01 2024-03-31 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:ZNWBAWarrantsMember 2024-03-31 0001131312 us-gaap:WarrantMember 2024-03-15 0001131312 us-gaap:WarrantMember 2024-04-15 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-03-31 0001131312 2018-04-02 0001131312 2018-04-02 2018-04-02 0001131312 us-gaap:WarrantMember 2018-04-02 0001131312 znogw:SubscriptionRightsOfferingMember 2018-06-29 0001131312 2018-12-04 2018-12-04 0001131312 2019-05-29 2019-05-29 0001131312 znogw:SubscriptionRightsOfferingMember 2023-01-01 2023-12-31 0001131312 us-gaap:WarrantMember 2019-05-29 0001131312 us-gaap:WarrantMember 2020-09-15 0001131312 us-gaap:WarrantMember 2022-03-21 0001131312 znogw:ZnwajWarrantsMember 2024-01-01 2024-03-31 0001131312 us-gaap:WarrantMember 2022-12-14 0001131312 us-gaap:WarrantMember 2022-12-28 0001131312 us-gaap:WarrantMember 2024-01-10 0001131312 us-gaap:EmployeeStockMember 2023-12-31 0001131312 us-gaap:EmployeeStockMember 2024-01-01 2024-03-31 0001131312 us-gaap:EmployeeStockMember 2024-03-31 0001131312 znogw:DividendReinvestmentAndStockPurchasePlanMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesOneMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesOneMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwoMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwoMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwoMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwoMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThreeMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThreeMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThreeMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThreeMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiveMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiveMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiveMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiveMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesSixMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesSixMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesSixMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesSixMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesSevenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesSevenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesSevenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesSevenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesEightMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesEightMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesEightMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesEightMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesNineMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesNineMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesNineMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesNineMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesElevenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesElevenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesElevenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesElevenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwelveMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwelveMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwelveMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwelveMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirteenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirteenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirteenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirteenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourteenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourteenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourteenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourteenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFifteenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFifteenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFifteenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFifteenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesSixteenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesSixteenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesSixteenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesSixteenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesSeventeenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesSeventeenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesSeventeenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesSeventeenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesEighteenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesEighteenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesEighteenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesEighteenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesNineteenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesNineteenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesNineteenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesNineteenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyOneMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyOneMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyOneMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyOneMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyTwoMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyTwoMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyTwoMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyTwoMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyThreeMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyThreeMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyThreeMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyThreeMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyFourMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyFourMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyFourMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyFourMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyFiveMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentyFiveMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyFiveMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyFiveMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentySixMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesTwentySixMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentySixMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentySixMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentySevenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentySevenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyEightMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyEightMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyNineMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesTwentyNineMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyOneMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyOneMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyOneMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyOneMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyTwoMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyTwoMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyTwoMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyTwoMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyThreeMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyThreeMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyFourMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyFourMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyFourMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyFourMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyFiveMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyFiveMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyFiveMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyFiveMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtySixMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtySixMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtySevenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtySevenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtySevenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtySevenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyEightMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyEightMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyEightMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyEightMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyNineMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesThirtyNineMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyNineMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesThirtyNineMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyOneMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyOneMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyOneMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyOneMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyTwoMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyTwoMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyTwoMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyTwoMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyThreeMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyThreeMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyThreeMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyThreeMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyFourMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyFourMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyFourMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyFourMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyFiveMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyFiveMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyFiveMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyFiveMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtySixMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtySixMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtySevenMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtySevenMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtySevenMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtySevenMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyEightMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyEightMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyEightMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyEightMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyNineMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFourtyNineMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyNineMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFourtyNineMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyOneMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyOneMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyOneMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyOneMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyTwoMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyTwoMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyTwoMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyTwoMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyThreeMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyThreeMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyThreeMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyThreeMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyFourMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyFourMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyFourMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyFourMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyFiveMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftyFiveMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyFiveMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftyFiveMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftySixMember 2024-03-31 0001131312 znogw:NonvestedMember znogw:RangesFiftySixMember 2024-01-01 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftySixMember 2024-03-31 0001131312 znogw:VestedMember znogw:RangesFiftySixMember 2024-01-01 2024-03-31 0001131312 znogw:NonvestedMember 2024-03-31 0001131312 znogw:NonvestedMember 2024-01-01 2024-03-31 0001131312 srt:MinimumMember znogw:VestedMember 2024-03-31 0001131312 srt:MaximumMember znogw:VestedMember 2024-03-31 0001131312 znogw:VestedMember 2024-03-31 0001131312 znogw:VestedMember 2024-01-01 2024-03-31 0001131312 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2024-01-01 2024-03-31 0001131312 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-01-01 2023-03-31 0001131312 znogw:EmployeesAndDirectorMember 2024-01-01 2024-03-31 0001131312 znogw:EmployeesAndDirectorMember 2023-01-01 2023-03-31 0001131312 znogw:NonEmployeesMember 2024-01-01 2024-03-31 0001131312 znogw:NonEmployeesMember 2023-01-01 2023-03-31 0001131312 znogw:EmployeesAndNonEmployeesMember 2024-01-01 2024-03-31 0001131312 znogw:EmployeesAndNonEmployeesMember 2023-01-01 2023-03-31 0001131312 znogw:ZNWAAMember znogw:WarrantTransactionsMember 2024-03-31 0001131312 znogw:ZNWAAMember znogw:WarrantTransactionsMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAAMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZNWANMember znogw:WarrantTransactionsMember 2024-03-31 0001131312 znogw:ZNWANMember znogw:WarrantTransactionsMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWANMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZNWAMMember znogw:WarrantTransactionsMember 2024-03-31 0001131312 znogw:ZNWAMMember znogw:WarrantTransactionsMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAMMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZNWAYWarrantsMember znogw:WarrantTransactionsMember 2024-03-31 0001131312 znogw:ZNWAYWarrantsMember znogw:WarrantTransactionsMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAYWarrantsMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZNWAZWarrantsMember znogw:WarrantTransactionsMember 2024-03-31 0001131312 znogw:ZNWAZWarrantsMember znogw:WarrantTransactionsMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAZWarrantsMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZnwaaWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001131312 znogw:ZnwaaWarrantsMember us-gaap:InvestorMember 2024-03-31 0001131312 znogw:ZnwamWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001131312 znogw:ZnwamWarrantsMember us-gaap:InvestorMember 2024-03-31 0001131312 znogw:ZNWAQWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAQWarrantsMember us-gaap:InvestorMember 2024-03-31 0001131312 znogw:ZnwasWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001131312 znogw:ZnwasWarrantsMember us-gaap:InvestorMember 2024-03-31 0001131312 znogw:ZnwatWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001131312 znogw:ZnwatWarrantsMember us-gaap:InvestorMember 2024-03-31 0001131312 znogw:ZNWAUWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAUWarrantsMember us-gaap:InvestorMember 2024-03-31 0001131312 znogw:ZNWAZWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWAZWarrantsMember us-gaap:InvestorMember 2024-03-31 0001131312 znogw:ZNWBAWarrantMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001131312 znogw:ZNWBAWarrantMember us-gaap:InvestorMember 2024-03-31 0001131312 country:IL 2024-03-31 0001131312 us-gaap:UseRightsMember 2024-01-01 2024-03-31 0001131312 us-gaap:UseRightsMember 2023-01-01 2023-03-31 0001131312 2023-11-16 0001131312 2023-11-16 2023-11-16 0001131312 2023-12-16 2023-12-16 0001131312 2023-12-28 0001131312 2023-12-13 2023-12-13 0001131312 2024-01-28 2024-01-28 0001131312 2024-03-12 0001131312 2024-02-23 2024-02-23 0001131312 us-gaap:SubsequentEventMember 2024-04-12 2024-04-12 0001131312 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember znogw:FourSuppliersMember 2024-01-01 2024-03-31 0001131312 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember znogw:ThreeSuppliersMember 2024-01-01 2024-03-31 0001131312 znogw:DSPPProgramMember us-gaap:SubsequentEventMember 2024-04-01 2024-05-07 xbrli:shares iso4217:USD iso4217:USD xbrli:shares utr:acre utr:sqkm xbrli:pure iso4217:USD compsci:item utr:sqft

EXHIBIT 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Robert W. A. Dunn, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Zion Oil & Gas, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 8, 2024  
   
/s/ Robert W.A. Dunn  
Robert W. A. Dunn, Chief Executive Officer  
(Principal Executive Officer)  
   

 

EXHIBIT 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Michael B. Croswell Jr, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Zion Oil & Gas, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 8, 2024  
   
/s/ Michael B. Croswell Jr.  
Michael B. Croswell Jr, Chief Financial Officer  
(Principal Financial and Accounting Officer)   

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Zion Oil and Gas, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Robert W.A. Dunn, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the Report.

 

/s/ Robert W.A. Dunn  
Robert W. A. Dunn  
Chief Executive Officer  
(Principal Executive Officer)  
May 8, 2024  

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Zion Oil and Gas, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Michael B. Croswell Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the Report.

 

/s/ Michal B. Croswell Jr.  
Michael B. Croswell Jr.  
Chief Financial Officer  
(Principal Financial and Accounting Officer)  
May 8, 2024  

 

v3.24.1.u1
Cover - shares
3 Months Ended
Mar. 31, 2024
May 06, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name ZION OIL & GAS, INC.  
Entity Central Index Key 0001131312  
Entity File Number 001-33228  
Entity Tax Identification Number 20-0065053  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 12655 N Central Expressway  
Entity Address, Address Line Two Suite 1000  
Entity Address, City or Town Dallas  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75243  
Entity Phone Fax Numbers [Line Items]    
City Area Code (214)  
Local Phone Number 221-4610  
Entity Listings [Line Items]    
Title of 12(b) Security N/A  
No Trading Symbol Flag true  
Security Exchange Name NONE  
Entity Common Stock, Shares Outstanding   733,547,697
v3.24.1.u1
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,115 $ 615
Fixed short term bank and escrow deposits – restricted 1,031 1,020
Prepaid expenses and other 415 515
Governmental receivables 27 18
Other receivables 445 123
Total current assets 3,033 2,291
Unproved oil and gas properties, full cost method (see Note 4) 16,943 16,637
Property and equipment at cost    
Drilling rig and related equipment, net of accumulated depreciation of $2,405 and $2,215 (see note 2I) 5,319 5,510
Property and equipment, net of accumulated depreciation of $693 and $686 75 74
Property and equipment, net 5,394 5,584
Right of Use Lease Assets (see Note 5) 956 194
Other assets    
Assets held for severance benefits 489 475
Total other assets 489 475
Total assets 26,815 25,181
Current liabilities    
Accounts payable 674 777
Insurance financing (see note 6D) 388 432
Lease obligation – current (see Note 5) 224 167
Asset retirement obligation 571 571
Accrued liabilities 617 693
Total current liabilities 2,474 2,640
Long-term liabilities    
Lease obligation – non-current (see Note 5) 708 24
Provision for severance pay 506 499
Total long-term liabilities 1,214 523
Total liabilities 3,688 3,163
Commitments and contingencies (see Note 6)
Stockholders’ equity    
Common stock, par value $.01; Authorized: 1,200,000,000 shares at March 31, 2024: Issued and outstanding: 709,445,335 and 640,002,580 shares at March 31, 2024 and December 31, 2023, respectively 7,094 6,400
Additional paid-in capital 304,354 302,177
Accumulated deficit (288,321) (286,559)
Total stockholders’ equity 23,127 22,018
Total liabilities and stockholders’ equity $ 26,815 $ 25,181
v3.24.1.u1
Consolidated Condensed Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Drilling rig and related equipment, net of accumulated depreciation (in Dollars) $ 2,405 $ 2,215
Accumulated depreciation (in Dollars) $ 693 $ 686
Common stock, par value (in Dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 1,200,000,000 1,200,000,000
Common stock, shares issued 709,445,335 640,002,580
Common stock, shares outstanding 709,445,335 640,002,580
v3.24.1.u1
Consolidated Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
General and administrative $ 1,175 $ 1,503
Other 599 583
Impairment of unproved oil and gas properties 45
Loss from operations (1,774) (2,131)
Other expense, net    
Foreign exchange (loss) 21 (2)
Financial gain (expenses), net (9) (6)
Loss before income taxes (1,762) (2,139)
Income taxes
Net loss $ (1,762) $ (2,139)
Net loss, per share of common stock    
Basic (in Dollars per share) $ 0 $ 0
Weighted-average shares outstanding    
Basic (in Shares) 667,023 531,023
v3.24.1.u1
Consolidated Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Diluted $ 0.00 $ 0.00
Diluted 667,023 531,023
v3.24.1.u1
Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2022 $ 5,242 $ 296,460 $ (278,602) $ 23,100
Balances (in Shares) at Dec. 31, 2022 524,231,000      
Funds received from sale of DSPP units and shares and exercise of warrants $ 94 698 792
Funds received from sale of DSPP units and shares and exercise of warrants (in Shares) 9,357,000      
Funds received from option exercises $ 1 7 8
Funds received from option exercises (in Shares) 125,000      
Value of options granted to employees, directors and others as non-cash compensation 417 417
Net loss (2,139) (2,139)
Balances at Mar. 31, 2023 $ 5,337 297,582 (280,741) 22,178
Balances (in Shares) at Mar. 31, 2023 533,713,000      
Balances at Dec. 31, 2023 $ 6,400 302,177 (286,559) $ 22,018
Balances (in Shares) at Dec. 31, 2023 640,002,000     640,002,580
Funds received from sale of DSPP units and shares and exercise of warrants $ 693 2,864 $ 3,557
Funds received from sale of DSPP units and shares and exercise of warrants (in Shares) 69,372,000      
Costs associated with the issuance of shares (816) (816)
Funds received from option exercises $ 1 6 7
Funds received from option exercises (in Shares) 71,000      
Value of options granted to employees, directors and others as non-cash compensation 123 123
Net loss (1,762) (1,762)
Balances at Mar. 31, 2024 $ 7,094 $ 304,354 $ (288,321) $ 23,127
Balances (in Shares) at Mar. 31, 2024 709,445,000     709,445,335
v3.24.1.u1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net loss $ (1,762) $ (2,139)
Adjustments required to reconcile net loss to net cash used in operating activities:    
Depreciation 192 200
Amortization of Right of Use Lease Assets 67 67
Cost of options issued to employees, directors and others as non-cash compensation 123 417
Post impairment of unproved oil and gas properties 45
Change in assets and liabilities, net:    
Other deposits 328
Prepaid expenses and other 100 19
Governmental receivables (9) 241
Other receivables (322) 4
Lease obligation – current and non-current (88) (71)
Severance payable, net (7) 3
Accounts payable (130) 26
Accrued liabilities (167) (57)
Net cash used in operating activities (2,003) (917)
Cash flows from investing activities    
Acquisition of property and equipment (7)
Investment in unproved oil and gas properties (317) (838)
Net cash used in investing activities (324) (838)
Cash flows from financing activities    
Proceeds from exercise of stock options 7 8
Costs paid related to the issuance of new shares (726)
Proceeds from issuance of stock and exercise of warrants 3,557 792
Net cash provided by financing activities 2,838 800
Net (decrease)/increase in cash, cash equivalents and restricted cash 511 (955)
Cash, cash equivalents and restricted cash – beginning of period 1,635 3,114
Cash, cash equivalents and restricted cash – end of period 2,146 2,159
Non-cash investing and financing activities:    
Depreciation of oil and gas equipment 5
Unpaid investments in oil & gas properties 659 1,515
Unpaid costs of issuance during 2024 90
Addition of right of use lease assets and lease obligations $ 829
v3.24.1.u1
Consolidated Condensed Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Statement of Cash Flows [Abstract]    
Cash and cash equivalents $ 1,115 $ 615
Restricted cash included in fixed long-term bank deposits 1,031 1,020
Total restricted cash $ 2,146 $ 1,635
v3.24.1.u1
Nature of Operations, Basis of Presentation and Going Concern
3 Months Ended
Mar. 31, 2024
Nature of Operations, Basis of Presentation and Going Concern [Abstract]  
Nature of Operations, Basis of Presentation and Going Concern

Note 1 - Nature of Operations, Basis of Presentation and Going Concern

 

A. Nature of Operations  

 

Zion Oil & Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is an oil and gas exploration company with a history of 24 years of oil & gas exploration in Israel. As of March 31, 2024, the Company has no revenues from its oil and gas operations.

 

Zion maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland. The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is to operate a foreign treasury center for the Company.

 

On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.

 

Zion has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition, Zion has the trademark filed with the Israeli Trademark Office in Israel.

 

Exploration Rights/Exploration Activities

 

New Megiddo Valleys License 434 (“NMVL 434”)

  

On September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil and gas exploration on approximately 75,000 acres or 302 square kilometers. This Exploration License 434 is valid for three years until September 13, 2026 with four potential 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes our previous NML 428.

  

On February 21, 2024, members of the Supervisory Committee visited our rig site. During this visit, they interacted with staff from Zion Oil & Gas, and our consultants and potential service providers. Some of these interactions occurred at Kibbutz Sde Eliyahu, while others were conducted through video conferencing with participants from the United States, Europe and the Middle East. Following these discussions, the Committee has officially accepted our work plan for the MJ-01 project. This acceptance allows us to sign agreements and secure mobilization dates with our service providers required to commence and complete the project.

 

We have begun working on visa applications for our rig crew in preparation for their entry into Israel. Upon the completion of the work visa process, the crew will travel to Israel and begin inspecting the rig to make sure it conforms to industry requirements for workover operations. Afterwards, the crew will rig down, slide the drilling rig over several meters and rig up on the MJ-01 well location. The crew will then open the well and continue to follow the approved work plan in conjunction with the selected service providers. This should occur toward the end of Q2 or early Q3 depending on subsurface conditions encountered during the reopening phase and contractor scheduling availability.

 

We have made strategic adjustments to control both cost and time. Despite the typical delays during Passover, which this year began on the evening of April 22nd and ended on the evening of April 30th, we have satisfied all regulatory requirements necessary to commence operations, including, as previously mentioned, approval by the Supervisory Committee. We are ready and moving forward.

 

B. Basis of Presentation  

 

The accompanying unaudited interim consolidated condensed financial statements of Zion Oil & Gas, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The year-end balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the operating results for the year ending December 31, 2024 or for any other subsequent interim period.

 

C. Going Concern  

 

The Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial production of hydrocarbons. 

 

The Company’s ability to continue as a going concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately generating profitable operations from its oil and natural gas interests in the future. The Company’s current operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern may be in doubt. The consolidated condensed financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. During the three months ended March 31, 2024, the Company incurred a net loss of approximately $1.8 million and had an accumulated deficit of approximately $288 million. These factors raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date the financials were issued.

 

To carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is not, the Company may be forced to curtail or cease exploration and development activities. The consolidated condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

v3.24.1.u1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

 

A. Net Loss per Share Data 

 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share for 2024 as the inclusion of 26,965,575 in stock options and 29,456,952 in warrants would be anti-dilutive.

 

Diluted net loss per share is the same as basic net loss per share for 2023 as the inclusion of 14,901,250 in stock options and 35,096,362 in warrants would be anti-dilutive.

 

B. Use of Estimates 

 

The preparation of the accompanying unaudited consolidated condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated condensed financial statements in future periods.

 

The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated condensed financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. We have made the same estimates as to the potential impact the Israel-Hamas war may have on our operations. Actual results may differ from these estimates.

 

C. Oil and Gas Properties and Impairment  

 

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

During the three months ended March 31, 2024, the Company did not record any post-impairment charges.

 

During the three months ended March 31, 2023, the Company recorded post-impairment charges of $45,000.

 

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $16,943,000 and $16,637,000 as of March 31, 2024 and December 31, 2023, respectively.

 

D. Fair Value Measurements  

 

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

 

Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

 

Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

The Company’s financial instruments, including cash and cash equivalents, other receivables. accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2024, and December 31, 2023, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.  

E. Stock-Based Compensation  

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated condensed financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

F. Warrants  

 

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

 

G. Related parties  

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.

 

Zion did not have any related party transactions for the periods covered in this report.

 

H. Recently Adopted Accounting Pronouncements  

 

In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies for fiscal years beginning after December 15, 2022 with early application permitted. Zion adopted ASU 2020-03 in the first quarter of 2023. The adoption of this ASU did not have any impact on its consolidated condensed financial statements.

 

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires companies to apply the definition of a performance obligation under ASC 606 to recognize and measure contract assets and contract liabilities relating to contracts with customers acquired in a business combination. Prior to the adoption of this ASU, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. The ASU results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. Zion adopted ASU 2021-08 in the first quarter of 2023. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements; the impact in future periods will be dependent upon the contract assets acquired and contract liabilities assumed in any future business combinations.

 

In September 2022, the FASB issued ASU No. 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-50). The ASU requires companies to disclose information about supplier finance programs, including key terms of the program, outstanding confirmed amounts as of the end of the period, a roll forward of such amounts during each annual period, and a description of where the amounts are presented. The new standard does not affect the recognition, measurement, or financial statement presentation of supplier finance obligations. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods, except for roll forward information, which is effective for fiscal years beginning after December 15, 2023. The adoption of this ASU did not have any impact on its consolidated condensed financial statements.

 

Other Recent Accounting Pronouncements

 

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2024 had a significant impact on our consolidated condensed financial position, results of operations, or cash flow.

I. Depreciation and Accounting for Drilling Rig and Related Equipment  

 

Zion purchased an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion is depreciating the rig on a straight-line basis.

 

Zion uses the First In First Out (“FIFO”) method of accounting for the spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the spare parts gets consumed.

 

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

 

See the table below for a reconciliation of the rig-related activity during the quarter ended March 31, 2024:

 

I-35 Drilling Rig & Associated Equipment:

 

   Three-month period ended March 31, 2024 
   I-35
Drilling
Rig
   Rig
Spare Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   
-
    
-
    
-
    
-
 
Asset Depreciation   (159)   
-
    (32)   (191)
Asset Disposals for Self-Consumption   
-
    
-
    
-
    
-
 
March 31, 2024   4,432    608    279    5,319 
v3.24.1.u1
Stockholders' Equity
3 Months Ended
Mar. 31, 2024
Stockholders Equity [Abstract]  
Stockholders' Equity

Note 3 - Stockholders’ Equity

 

The Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 800,000,000 shares to 1,200,000,000 shares, effective June 7, 2023.

 

A. 2021 Omnibus Incentive Stock Option Plan 

 

Effective June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares of common stock.

 

The Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments under certain conditions.

 

The compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award, when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable for a period not to exceed ten years from the date of grant.

 

During the three months ended March 31, 2024, the Company granted the following options from the 2021 Equity Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

i.Options to purchase 175,000 shares of Common Stock to five senior officers and two staff members at an exercise price of $0.07 per share. The options vested upon grant and are exercisable through January 4, 2034. The fair value of the options at the date of grant amounted to approximately $11,000.

 

ii.Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2034. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,800.

 

During the three months ended March 31, 2023, the Company granted the following options from the 2021 Equity Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

i.Options to purchase 175,000 shares of Common Stock to five senior officers and one staff member at an exercise price of $0.0615 per share. The options vested upon grant and are exercisable through January 4, 2033. The fair value of the options at the date of grant amounted to approximately $9,000.

 

ii.Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,500.

 

B. Stock Options  

 

The stock option transactions since January 1, 2024 are shown in the table below:

 

   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2023   34,091,250    0.23 
           
Changes during 2024 to:          
Granted to employees, officers, directors and others   200,000    0.07 
Expired/Cancelled/Forfeited   (250,000)   2.31 
Exercised   (70,675)   0.10 
Outstanding, March 31, 2024   33,970,575    0.22 
Exercisable, March 31, 2024   26,965,575    0.25 

 

The following table summarizes information about stock options outstanding as of March 31, 2024:

 

Shares underlying outstanding options (non-vested)  Shares underlying outstanding options (fully vested) 
Range of
exercise
price
  Number
outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
   Range of
exercise
price
   Number
Outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
 
US$          US$   US$           US$ 
0.07   7,005,000    9.48    0.07                 
   
    
    
    0.01    5,000    0.20    0.01 
   
    
    
    0.01    20,000    2.18    0.01 
   
    
    
    0.01    130,000    2.76    0.01 
   
    
    
    0.01    50,000    2.76    0.01 
   
    
    
    0.01    60,000    3.05    0.01 
   
    
    
    0.01    200,000    3.14    0.01 
   
    
    
    0.01    40,000    3.50    0.01 
   
    
    
    0.01    70,000    3.76    0.01 
   
    
    
    0.01    25,000    3.76    0.01 
   
    
    
    0.01    30,000    3.92    0.01 
   
    
    
    0.01    4,000    4.02    0.01 
   
    
    
    0.01    25,000    4.77    0.01 
   
    
    
    0.01    35,000    5.47    0.01 
   
    
    
    0.01    150,000    5.64    0.01 
   
    
    
    0.01    35,000    5.77    0.01 
   
    
    
    0.01    75,000    6.77    0.01 
   
    
    
    0.01    200,000    7.14    0.01 
   
    
    
    0.01    300,000    7.30    0.01 
   
    
    
    0.01    10,000    7.42    0.01 
   
    
    
    0.01    500,000    7.77    0.01 
   
    
    
    0.01    55,000    7.80    0.01 
   
    
    
    0.01    960,000    8.05    0.01 
   
    
    
    0.01    75,000    8.37    0.01 
   
    
    
    0.01    10,000    8.43    0.01 
   
    
    
    0.01    795,000    8.49    0.01 
               0.01    25,000    8.77    0.01 
               0.01    10,000    9.43    0.01 
               0.01    895,000    9.48    0.01 
               0.01    25,000    9.77    0.01 
   
    
    
    0.06    50,000    8.77    0.06 
   
    
    
    0.07    25,000    9.19    0.07 
               0.07    125,000    9.77    0.07 
   
    
    
    0.14    240,000    7.80    0.14 
   
    
    
    0.15    3,200,000    7.77    0.15 
               0.15    6,389,325    8.05    0.15 
   
    
    
    0.16    340,000    1.70    0.16 
   
    
    
    0.16    75,000    5.70    0.16 
   
    
    
    0.18    25,000    1.67    0.18 
               0.18    5,155,000    8.49    0.18 
   
    
    
    0.24    25,000    8.34    0.24 
   
    
    
    0.24    118,000    8.37    0.24 
   
    
    
    0.25    50,000    7.42    0.25 
   
    
    
    0.25    363,000    7.42    0.25 
   
    
    
    0.28    25,000    1.43    0.28 
               0.28    25,000    5.43    0.28 
   
    
    
    0.29    25,000    3.21    0.29 
   
    
    
    0.39    1,435,000    7.28    0.39 
   
    
    
    0.59    1,400,000    3.14    0.59 
   
    
    
    0.59    1,600,000    7.14    0.59 
   
    
    
    0.92    350,000    2.76    0.92 
   
    
    
    0.92    550,000    6.77    0.92 
   
    
    
    1.38    105,307    0.76    1.38 
   
    
    
    1.67    405,943    0.50    1.67 
   
    
    
    1.78    25,000    0.43    1.78 
   
    
    
    4.15    25,000    0.25    4.15 
0.07   7,005,000    
 
    0.07    0.01-4.15    26,965,575         
0.25

  

Granted to employees 

 

The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the three months ended March 31, 
   2024   2023 
Weighted-average fair value of underlying stock at grant date  $0.07   $0.06 
Dividend yields   
    
 
Expected volatility   133%   137%
Risk-free interest rates   3.97%   3.85%
Expected lives (in years)   5.00    5.00 
Weighted-average grant date fair value  $0.07   $0.06 

 

C. Compensation Cost for Warrant and Option Issuances  

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:

 

For the three months ended March 31, 
2024   2023 
US$ thousands   US$ thousands 
 122    415 

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:

 

For the three months ended March 31, 
2024   2023 
US$ thousands   US$ thousands 
 1    2 

 

The following table sets forth information about the compensation cost of option issuances recognized for employees and non-employees and capitalized to Unproved Oil & Gas properties:

 

For the three months ended March 31,  
2024     2023  
US$ thousands     US$ thousands  
       

 

As of March 31, 2024, there was $211,000 of unrecognized compensation cost related to non-vested stock options granted under the Company’s various stock option plans. That cost is expected to be recognized during 2024.

 

D. Dividend Reinvestment and Stock Purchase Plan (“DSPP  ”)

 

On March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three-year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of May 2, 2023, any outstanding ZNWAD warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of May 1, 2023, any outstanding ZNWAE warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of August 14, 2023, any outstanding ZNWAF warrants expired.

 

On December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January 8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of January 8, 2024, any outstanding ZNWAG warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 2, 2021 to April 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of April 2, 2023, any outstanding ZNWAH warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 29, 2023, any outstanding ZNWAJ warrants expired.

  

On September 15, 2020, the Company extended the termination date of the ZNWAK warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of February 25, 2023, any outstanding ZNWAK warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of August 26, 2023, any outstanding ZNWAL warrants expired.

 

Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022.

 

On March 21, 2022, the Company extended the termination date of the ZNWAM warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023 and revised the exercise price to $0.05. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On June 16, 2023, the Company extended the termination date of the ZNWAM warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2023, the Company extended the termination date of the ZNWAM warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 19, 2023, the Company extended the termination date of the ZNWAM warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On December 18, 2023, the Company extended the termination date of the ZNWAM warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On March 28, 2024, the Company extended the termination date of the ZNWAM warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

The ZNWAN warrants became exercisable on May 16, 2021 and continue to be exercisable through May 16, 2023 at a per share exercise price of $1.00.

 

As of May 16, 2023, any outstanding ZNWAN warrants expired.

 

The ZNWAO warrants became exercisable on June 12, 2021 and continue to be exercisable through June 12, 2023 at a per share exercise price of $.25.

 

As of June 12, 2023, any outstanding ZNWAO warrants expired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of a Unit (shares of stock and warrants) to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25.

 

On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

During the second quarter of 2022, all warrants represented by ZNWAP and ZNWAR were exercised resulting in a net cash inflow of approximately $365,000.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued on May 5, 2022 and were exercisable through July 15, 2023 at a revised per share exercise price of $.05.

 

Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On June 16, 2023, the Company extended the termination date of the ZNWAQ warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2023, the Company extended the termination date of the ZNWAQ warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 19, 2023, the Company extended the termination date of the ZNWAQ warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

  

On December 18, 2023, the Company extended the termination date of the ZNWAQ warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On March 28, 2024, the Company extended the termination date of the ZNWAQ warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continue to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 during 2021 in equity issuance costs to an outside party related to this waiver program.

 

On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

During the second quarter of 2022, all warrants represented by ZNWAP and ZNWAR were exercised resulting in a net cash inflow of approximately $365,000.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a revised per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on September 30, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAT.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on December 31, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAU.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a program consisting of shares of stock to a participant. After conclusion of the program on August 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Zion incurred $173,000 in equity issuance costs to an outside party related to this waiver program. The Company executed two additional Waiver Term Sheets with a participant consisting of shares of stock. After conclusion of the program on December 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. During the year ended December 31, 2023, Zion incurred $1,120,000 in equity issuance costs.

 

On January 1, 2024, the Company executed a Waiver Term Sheet with a participant consisting of shares of stock. After conclusion of the program on March 31, 2024, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. During the quarter ended March 31, 2024, Zion incurred $816,000 in equity issuance costs. During the quarter ended March 31, 2023, Zion did not incur any equity issuance costs.

 

On April 1, 2024, the Company executed its latest Waiver Term Sheet with a participant consisting of shares of stock. This latest Waiver Term Sheet terminates at the earlier of: (a) a maximum purchase of $10,000,000 through the DSPP, (b) October 1, 2024 or (c) the closing price of Zion’s stock is 15 cents per share for five (5) consecutive days.

 

During 2024, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 59% of the net cash raised through the DSPP. 

 

During 2023, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 54% of the net cash raised through the DSPP.

 

On March 13, 2023, Zion filed with the Securities and Exchange Commission an Amendment No. 2 to the Prospectus Supplement dated as of December 15, 2021 and accompanying base prospectus dated December 1, 2021 relating to the Company’s Dividend Reinvestment and Direct Stock Purchase Plan. The Prospectus forms a part of the Company’s Registration Statement on Form S-3 (File No. 333-261452), as amended, which was declared effective by the SEC on December 15, 2021.

 

Amendment No. 2 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under Amendment No. 2. Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 2 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option had up to three tranches of investment, in which the second and third tranches were each subject to termination upon a total of $7,500,000 received from participants by the Company during the first or second tranche. The first tranche period began on March 13, 2023 and terminated on March 26, 2023. The second tranche began on March 27, 2023 and terminated on April 9, 2023 and the third tranche began on April 10, 2023 and terminated on April 27, 2023.

 

The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional five hundred (500) shares of Common Stock at a per share exercise price of $0.05. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.05. The warrant shall have the Company notation of “ZNWAV” under the first tranche, “ZNWAW” under the second tranche and “ZNWAX” under the third tranche.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price of $0.05 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and shall have the Company notation of “ZNWAY.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they purchased at least one (1) Unit during the Unit program. Plan participants, who enrolled in the AMI at a minimum of $100 per month, received one hundred (100) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $250 per month, received two hundred and fifty (250) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $500 per month, received five hundred (500) ZNWAY warrants. The AMI program required 90 days of participation to receive the ZNWAY warrants. Existing AMI participants were entitled to participate in this monthly program by increasing their monthly amount above the minimum $50.00 per month.

 

The ZNWAV warrants became exercisable on March 31, 2023 and continued to be exercisable through June 28, 2023 at a per share exercise price of $0.05.

 

As of June 28, 2023, any outstanding ZNWAV warrants expired.

 

The ZNWAW warrants became exercisable on April 14, 2023 and continued to be exercisable through July 13, 2023 at a per share exercise price of $0.05.

 

As of July 13, 2023, any outstanding ZNWAW warrants expired.

 

The ZNWAX warrants became exercisable on May 2, 2023 and continued to be exercisable through July 31, 2023 at a per share exercise price of $0.05.

 

On July 31, 2023, any outstanding ZNWAX warrants expired.

 

The ZNWAY warrants became exercisable on June 12, 2023 and continued to be exercisable through September 10, 2023 at a per share exercise price of $0.05.

 

On September 10, 2023, any outstanding ZNWAY warrants expired.

 

Amendment No. 3 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under Amendment No. 3. This Unit Option period began on May 15, 2023 and terminated on June 15, 2023.

 

Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1 and Amendment No.2. Amendment No. 3 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. As mentioned above, this Unit Option began on May 15, 2023 and terminated on June 15, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional two hundred (200) shares of Common Stock at a per share exercise price of $0.25. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWAZ” and will not be registered for trading on the OTCQB or any other stock market or trading market.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional three hundred (300) warrants at an exercise price of $0.25 during this Unit Option Program. The three hundred (300) additional warrants were for enrolling into the AMI program and received the above warrant with the Company notation of “ZNWAZ.” Existing subscribers to the AMI were entitled to the additional three hundred (300) warrants, if they purchased at least one (1) Unit during the Unit program.

 

The ZNWAZ warrants became exercisable on July 17, 2023 and continue to be exercisable through July 17, 2024 at a per share exercise price of $0.25.

 

Amendment No. 4 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under our Unit Program with this Amendment No. 4. This Unit Option period began on November 6, 2023 and was scheduled to terminate on December 31, 2023. See Amendment No 5 below for data on an extension.

 

Our Unit Program consists of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 4 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option began on November 6, 2023 and terminated on December 31, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $0.25. The participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWBA” and will not be registered for trading on the OTCQB or any other stock market or trading market.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and received the above warrant with the Company notation of “ZNWBA.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they purchased at least one (1) Unit during the Unit program.

 

The ZNWBA warrants became exercisable on January 15, 2024, and continue to be exercisable through January 15, 2025, unless extended, at a per share exercise price of $0.25. See Amendment No. 5 below for new dates.

 

Amendment No. 5 – Extension of Termination Date to January 31, 2024

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consisted of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended the Unit Program that was to terminate December 31, 2023, but now was scheduled to terminate on January 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on February 15, 2024, instead of January 15, 2024 and continue to be exercisable through February 15, 2025, instead of January 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.

 

The date of this Amendment No. 5 to Prospectus Supplement was December 20, 2023.

 

Amendment No. 6 – Extension of Termination Date to February 29, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended the Unit Program that was to terminate January 31, 2024, but now was scheduled to terminate February 29, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on March 15, 2024, instead of February 15, 2024 and continue to be exercisable through March 15, 2025, instead of February 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 6 to Prospectus Supplement was January 29, 2024.

 

Amendment No. 7 – Extension of Termination Date to March 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate February 29, 2024, but now will terminate March 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on April 15, 2024, instead of March 15, 2024 and continue to be exercisable through April 15, 2025, instead of March 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 7 to Prospectus Supplement was February 26, 2024.

 

Amendment No. 8 – Extension of Termination Date to April 30, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate March 31, 2024, but now will terminate April 30, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on May 15, 2024, instead of April 15, 2024 and continue to be exercisable through May 15, 2025, instead of April 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 8 to Prospectus Supplement was March 23, 2024.

 

Amendment No. 9 – Extension of Termination Date to May 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate April 30, 2024, but now will terminate May 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on June15, 2024, instead of May 15, 2024 and continue to be exercisable through June 15, 2025, instead of May 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 9 to Prospectus Supplement was April 24, 2024.

 

For the three months ended March 31, 2024, and 2023, approximately $3,557,000 and $792,000 were raised under the DSPP program, respectively. The $3,557,000 figure was reduced by $816,000 in equity issuance costs to an outside party resulting in net cash provided of $2,741,000.

 

The company raised approximately $1,959,000 from the period April 1, 2024 through May 7, 2024, under the DSPP program.

 

The warrants represented by the company notation ZNWAA are tradeable on the OTCQB market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-Q, are not tradeable and are used internally for classification and accounting purposes only.

 

E. Subscription Rights Offering  

 

On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”

 

The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.

 

On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of June 29, 2023, any outstanding ZNWAI warrants expired.

 

Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.

 

The 2018 Subscription Rights Offering terminated on May 31, 2018. The Company raised net proceeds of approximately $3,038,000, from the subscription of Rights, after deducting fees and expenses of $243,000 incurred in connection with the rights offering.

 

F. Warrant Table  

 

The warrants balances at December 31, 2023 and transactions since January 1, 2024 are shown in the table below:

 

Warrants  Exercise
Price
   Warrant
Termination
Date
  Outstanding
Balance,
12/31/2023
   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding
Balance,
03/31/2024
 
ZNWAA  $2.00   01/31/2025   1,498,804    
-
    
-
    
-
    1,498,804 
ZNWAG  $1.00   01/08/2024   240,068    
-
    
-
    (240,068)   
-
 
ZNWAM  $0.05   12/31/2024   4,376,000    
-
    
-
    
-
    4,376,000 
ZNWAQ  $0.05   12/31/2024   23,428,348    
-
    
-
    
-
    23,428,348 
ZNWAZ  $0.25   07/17/2024   153,800         
-
    
-
    153,800 
Outstanding warrants           29,697,020    
            -
    
         -
    (240,068)   29,456,952 

G. Warrant Descriptions  

 

The price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those warrants with an expiration date beyond the balance sheet date.

 

 

 

      Period of Grant   US$     Expiration Date
ZNWAA Warrants   A,B,E,I   March 2013 – December 2014     2.00     January 31, 2025
ZNWAM Warrants   C,F,J,K   January 2021 – March 2021     0.05     December 31, 2024
ZNWAQ Warrants   C,F,J,K   June 2021     0.05     December 31, 2024
ZNWAS Warrants   D   August 2021 – March 2022     0.25     December 31, 2025
ZNWAT Warrants   D   August – September 2022     0.25     December 31, 2025
ZNWAU Warrants   D   October – November 2022     0.25     December 31, 2025
ZNWAZ Warrants   G   May – June 2023     .25     July 17, 2024
ZNWBA Warrants   H   November – December 2023     .25     June 15, 2025 

 

A On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year.
   
B On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years.
   
C On March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023.
   
D These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025.
   
E On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year.
   
F The warrant exercise price was lowered to $0.05 on December 28, 2022.
   
G On May 15, 2023, the Company announced a new Unit Offering and the related ZNWAZ warrant. 

 

H On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant.

 

I On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year.

 

J On December 18, 2023, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to March 31, 2024.

 

K On March 23, 2024, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to December 31, 2024.
v3.24.1.u1
Unproved Oil and Gas Properties, Full Cost Method
3 Months Ended
Mar. 31, 2024
Unproved Oil and Gas Properties, Full Cost Method [Abstract]  
Unproved Oil and Gas Properties, Full Cost Method

Note 4 - Unproved Oil and Gas Properties, Full Cost Method 

 

Unproved oil and gas properties, under the full cost method, are comprised as follows:

 

   March 31,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   2,592    2,538 
Capitalized salary costs   2,470    2,444 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   10,424    10,198 
Other costs   39    39 
    16,943    16,637 

 

Post-impairment of unproved oil and gas properties comprised as follows: 

 

   For the three months ended
March 31,
 
   2024   2023 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   
        -
    11 
Capitalized salary costs   
-
    
-
 
Capitalized interest costs   
-
    
-
 
Legal and seismic costs, license fees and other preparation costs   
-
    34 
    
-
    45 

 

 

Changes in Unproved oil and gas properties during the three months ended March 31, 2024 and 2023 are as follows:

 

   March 31,
2024
   March 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:          
Drilling costs, and other operational related costs   54    63 
Capitalized salary costs   26    26 
Capitalized interest costs   
-
    
-
 
Legal and seismic costs, license fees and other preparation costs   226    124 
Other costs   
-
    
-
 
Impairment of unproved oil and gas properties   
-
    (45)
    *306   *168

 

* Inclusive of non-cash amounts of approximately $664,000, and $1,515,000 during the three months ended March 31, 2024, and 2023, respectively

 

Please refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.

v3.24.1.u1
Right of Use Lease Assets and Lease Obligations
3 Months Ended
Mar. 31, 2024
Right of Use Lease Assets and Lease Obligations [Abstract]  
Right of use lease assets and lease obligations

Note 5 - Right of use lease assets and lease obligations  

 

The Company is a lessee in several non-cancellable operating leases for transportation and office space.

 

The table below presents the operating lease assets and liabilities recognized on the balance sheets as of March 31, 2024 and December 31, 2023: 

 

   March 31,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Operating lease assets  $956   $194 
           
Operating lease liabilities:          
Current operating lease liabilities  $224   $167 
Non-current operating lease liabilities  $708   $24 
Total operating lease liabilities  $932   $191 

 

The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.

 

The Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date.

 

The Company’s field office in Caesarea, Israel is under lease for 6,566 square feet.

 

The Company had an option to renew the lease for another five years from February 1, 2024 to January 31, 2029, provided it is not in breach of the agreement, where it is required as well to furnish a notice of intent to exercise the option six months prior to termination of lease, and it furnishes a bank guarantee and insurance confirmation prior to commencement of the option period. The Company exercised the option to renew the lease for another seven years from February 1, 2024 through January 31, 2031, when rent is to be paid on a monthly basis in the base amount of approximately NIS 46,500 per month (approximately $12,800) at the exchange rate in effect on the date of this report and is linked to an increase (but not a decrease) in the CPI.

 

The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of March 31, 2024 are:

 

   March 31,
2024
 
Weighted average remaining lease term (years)   6.00 
Weighted average discount rate   7.62%

 

The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of March 31, 2024:

 

   US$
thousands
 
2024   281 
2025   156 
2026   155 
2027   150 
2028   150 
Thereafter   275 
Total undiscounted future minimum lease payments   1,167 
Less: portion representing imputed interest   (235)
Total undiscounted future minimum lease payments   932 

 

Operating lease costs were $75,000 and $69,000 for the three months ended March 31, 2024, and 2023, respectively. Operating lease costs are included within general and administrative expenses on the statements of operations.

 

Cash paid for amounts included in the measurement of operating lease liabilities was $88,000 and $70,000 for the three months ended March 31, 2024, and 2023, respectively, and this amount is included in operating activities in the statements of cash flows.

 

Right-of-use assets obtained in exchange for new operating lease liabilities were $829 and $nil for the three months ended March 31, 2024, and 2023, respectively.

v3.24.1.u1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

Note 6 - Commitments and Contingencies

 

A. Litigation  

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. 

 

The Company is not subject to any litigation at the present time. 

 

B. Market Conditions – Coronavirus, Israel-Hamas War and Russia-Ukraine War 

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.

 

On October 7, 2023, Hamas, a militant terrorist organization in Gaza, infiltrated southern Israel, killing and injuring at least one thousand Israeli citizens. Roughly 250 Israeli hostages were then taken back to Gaza. This unprovoked attack led the nation of Israel to declare war on Hamas approximately one week later. As of the date of this report, Israel remains at war and there are daily battles inside the Gaza strip. Israel’s stated goals are to completely dismantle the terror infrastructure of Gaza, including its extensive tunnel network and to bring back safely all of the hostages.

 

There is uncertainty as to how long the war inside the Gaza strip will last and whether the war will expand to other hostile parties in the region. While we acknowledge that uncertainty and its potential adverse effects on Zion’s business, the Company is moving forward with its planning and logistics activities. We are working with our international service providers on projected availability timelines and other details. All of these key vendors have expressed willingness to assist Zion in its exploration activities. It is important to note that Zion’s license area is not located near any current combat zones.

 

Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although the Russian war against Ukraine did not have a material adverse impact on the Company’s financial results for the quarter ended March 31, 2024, at this time the Company is unable to fully assess the aggregate impact the Russian war against Ukraine will have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the global economy, future energy pricing, its impact to the businesses of the Company’s, and actions that may be taken by governmental authorities related to the war.

 

C. Environmental and Onshore Licensing Regulatory Matters  

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous Zion filings.

 

The Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to obtain all of the necessary authorizations and approvals to drill and production test exploration wells.

 

As of March 31, 2024, and December 31, 2023, the Company accrued $nil and $nil for license regulatory matters.

D. Insurance Financing 

 

Effective November 16, 2023, the Company renewed its third-party liability (“TPL”) insurance policy in Israel with total premiums, taxes and fees for $76,263. A cash down payment of $22,699 was paid on November 16, 2023. Under the terms of the insurance financing, payments of $5,356, which include interest at the rate of 13.99% per annum, are due each month for 10 months commencing on December 16, 2023.

 

Effective December 28, 2023, the Company renewed its D&O insurance policy with total premiums, taxes and fees for $441,598. A cash down payment of $68,733 was paid on December 13, 2023. Under the terms of the insurance financing, payments of $37,287, which include interest at the rate of 13.4% per annum, are due each month for 10 months commencing on January 28, 2024.

 

Effective March 12, 2024, 2024, the Company renewed its rig insurance policy with total premiums, taxes and fees for $94,989. A cash down payment of $37,637 was paid on February 23, 2024. Under the terms of the insurance financing, payments of $9,499, which include interest at the rate of 13.99% per annum, are due each month for 10 months commencing on April 12, 2024.

 

As of March 31, 2024 and 2023, the Company had contractual obligations to pay for various lines of insurance, including directors and officers, rig and third-party liability. The balances for insurance financing were $388,000 and $432,000, respectively. 

 

We haven’t experienced any resistance from our insurance carriers as a result of the Israel-Hamas war, but we acknowledge the uncertainty the war creates in that respect.

 

E. Bank Guarantees  

 

As of March 31, 2024, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $944,000) and others (approximately $87,000) with respect to its drilling operation in an aggregate amount of approximately $1,031,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits – restricted.

 

F. Vendor Concentration 

 

The Company’s financial instruments that are exposed to a concentration of credit risk are accounts payable. At March 31, 2024, there were four suppliers that represent 10% or more of the Company’s accounts payable balance. At December 31, 2023, there were three suppliers that represent 10% or more of the Company’s accounts payable balance.

 

G. Risks 

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2024 through March 31, 2024, the USD has fluctuated by approximately 1.5% against the NIS (the USD strengthened relative to the NIS). Also, during the period January 1, 2023 through December 31, 2023, the USD fluctuated by approximately 3.1% against the NIS (the USD strengthened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2024, we had cash, cash equivalents and short-term bank deposits of approximately $2,146,000. The weighted average annual interest rate related to our cash and cash equivalents for the three months ended March 31, 2024, exclusive of funds at US banks that earn no interest, was approximately 3.20%.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

v3.24.1.u1
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events

Note 7 - Subsequent Events

 

  (i) Approximately $1,959,000 was collected through the Company’s DSPP program during the period April 1 through May 7, 2024 .
v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ (1,762) $ (2,139)
v3.24.1.u1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.1.u1
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]  
Net Loss per Share Data

A. Net Loss per Share Data 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share for 2024 as the inclusion of 26,965,575 in stock options and 29,456,952 in warrants would be anti-dilutive.

Diluted net loss per share is the same as basic net loss per share for 2023 as the inclusion of 14,901,250 in stock options and 35,096,362 in warrants would be anti-dilutive.

Use of Estimates

B. Use of Estimates 

The preparation of the accompanying unaudited consolidated condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated condensed financial statements in future periods.

The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated condensed financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. We have made the same estimates as to the potential impact the Israel-Hamas war may have on our operations. Actual results may differ from these estimates.

Oil and Gas Properties and Impairment

C. Oil and Gas Properties and Impairment  

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

During the three months ended March 31, 2024, the Company did not record any post-impairment charges.

During the three months ended March 31, 2023, the Company recorded post-impairment charges of $45,000.

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $16,943,000 and $16,637,000 as of March 31, 2024 and December 31, 2023, respectively.

Fair Value Measurements

D. Fair Value Measurements  

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;
Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and
Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

The Company’s financial instruments, including cash and cash equivalents, other receivables. accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2024, and December 31, 2023, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.  

Stock Based Compensation

E. Stock-Based Compensation  

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated condensed financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

Warrants

F. Warrants  

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

Related parties

G. Related parties  

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.

Zion did not have any related party transactions for the periods covered in this report.

 

Recently Adopted Accounting Pronouncements

H. Recently Adopted Accounting Pronouncements  

In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments”: The amendments in this update are to clarify, correct errors in, or make minor improvements to a variety of ASC topics. The changes in ASU 2020-03 are not expected to have a significant effect on current accounting practices. The ASU improves various financial instrument topics in the Codification to increase stakeholder awareness of the amendments and to expedite the improvement process by making the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. The ASU is effective for smaller reporting companies for fiscal years beginning after December 15, 2022 with early application permitted. Zion adopted ASU 2020-03 in the first quarter of 2023. The adoption of this ASU did not have any impact on its consolidated condensed financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires companies to apply the definition of a performance obligation under ASC 606 to recognize and measure contract assets and contract liabilities relating to contracts with customers acquired in a business combination. Prior to the adoption of this ASU, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. The ASU results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. Zion adopted ASU 2021-08 in the first quarter of 2023. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements; the impact in future periods will be dependent upon the contract assets acquired and contract liabilities assumed in any future business combinations.

In September 2022, the FASB issued ASU No. 2022-04, Liabilities – Supplier Finance Programs (Subtopic 405-50). The ASU requires companies to disclose information about supplier finance programs, including key terms of the program, outstanding confirmed amounts as of the end of the period, a roll forward of such amounts during each annual period, and a description of where the amounts are presented. The new standard does not affect the recognition, measurement, or financial statement presentation of supplier finance obligations. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods, except for roll forward information, which is effective for fiscal years beginning after December 15, 2023. The adoption of this ASU did not have any impact on its consolidated condensed financial statements.

Other Recent Accounting Pronouncements

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2024 had a significant impact on our consolidated condensed financial position, results of operations, or cash flow.

Depreciation and Accounting for Drilling Rig and Related Equipment

I. Depreciation and Accounting for Drilling Rig and Related Equipment  

Zion purchased an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion is depreciating the rig on a straight-line basis.

Zion uses the First In First Out (“FIFO”) method of accounting for the spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the spare parts gets consumed.

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

See the table below for a reconciliation of the rig-related activity during the quarter ended March 31, 2024:

I-35 Drilling Rig & Associated Equipment:

   Three-month period ended March 31, 2024 
   I-35
Drilling
Rig
   Rig
Spare Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   
-
    
-
    
-
    
-
 
Asset Depreciation   (159)   
-
    (32)   (191)
Asset Disposals for Self-Consumption   
-
    
-
    
-
    
-
 
March 31, 2024   4,432    608    279    5,319 
v3.24.1.u1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]  
Schedule of Drilling Rig & Associated Equipment I-35 Drilling Rig & Associated Equipment
   Three-month period ended March 31, 2024 
   I-35
Drilling
Rig
   Rig
Spare Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   
-
    
-
    
-
    
-
 
Asset Depreciation   (159)   
-
    (32)   (191)
Asset Disposals for Self-Consumption   
-
    
-
    
-
    
-
 
March 31, 2024   4,432    608    279    5,319 
v3.24.1.u1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders' Equity (Tables) [Line Items]  
Schedule of Stock Option Transactions The stock option transactions since January 1, 2024 are shown in the table below:
   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2023   34,091,250    0.23 
           
Changes during 2024 to:          
Granted to employees, officers, directors and others   200,000    0.07 
Expired/Cancelled/Forfeited   (250,000)   2.31 
Exercised   (70,675)   0.10 
Outstanding, March 31, 2024   33,970,575    0.22 
Exercisable, March 31, 2024   26,965,575    0.25 

 

Schedule of Warrants Transactions The warrants balances at December 31, 2023 and transactions since January 1, 2024 are shown in the table below:
Warrants  Exercise
Price
   Warrant
Termination
Date
  Outstanding
Balance,
12/31/2023
   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding
Balance,
03/31/2024
 
ZNWAA  $2.00   01/31/2025   1,498,804    
-
    
-
    
-
    1,498,804 
ZNWAG  $1.00   01/08/2024   240,068    
-
    
-
    (240,068)   
-
 
ZNWAM  $0.05   12/31/2024   4,376,000    
-
    
-
    
-
    4,376,000 
ZNWAQ  $0.05   12/31/2024   23,428,348    
-
    
-
    
-
    23,428,348 
ZNWAZ  $0.25   07/17/2024   153,800         
-
    
-
    153,800 
Outstanding warrants           29,697,020    
            -
    
         -
    (240,068)   29,456,952 

Schedule of Weighted-Average Fair Value of Options Granted The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:
   For the three months ended March 31, 
   2024   2023 
Weighted-average fair value of underlying stock at grant date  $0.07   $0.06 
Dividend yields   
    
 
Expected volatility   133%   137%
Risk-free interest rates   3.97%   3.85%
Expected lives (in years)   5.00    5.00 
Weighted-average grant date fair value  $0.07   $0.06 
Schedule of Compensation Cost of Warrant and Option Issuances The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:
For the three months ended March 31, 
2024   2023 
US$ thousands   US$ thousands 
 122    415 
For the three months ended March 31, 
2024   2023 
US$ thousands   US$ thousands 
 1    2 
For the three months ended March 31,  
2024     2023  
US$ thousands     US$ thousands  
       
Schedule of Warrants with an Expiration The price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those warrants with an expiration date beyond the balance sheet date.

 

 

      Period of Grant   US$     Expiration Date
ZNWAA Warrants   A,B,E,I   March 2013 – December 2014     2.00     January 31, 2025
ZNWAM Warrants   C,F,J,K   January 2021 – March 2021     0.05     December 31, 2024
ZNWAQ Warrants   C,F,J,K   June 2021     0.05     December 31, 2024
ZNWAS Warrants   D   August 2021 – March 2022     0.25     December 31, 2025
ZNWAT Warrants   D   August – September 2022     0.25     December 31, 2025
ZNWAU Warrants   D   October – November 2022     0.25     December 31, 2025
ZNWAZ Warrants   G   May – June 2023     .25     July 17, 2024
ZNWBA Warrants   H   November – December 2023     .25     June 15, 2025 
A On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year.
   
B On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years.
   
C On March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023.
   
D These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025.
   
E On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year.
   
F The warrant exercise price was lowered to $0.05 on December 28, 2022.
   
G On May 15, 2023, the Company announced a new Unit Offering and the related ZNWAZ warrant. 
H On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant.
I On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year.
J On December 18, 2023, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to March 31, 2024.
K On March 23, 2024, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to December 31, 2024.
Dividend Reinvestment And Stock Purchase Plan [Member]  
Stockholders' Equity (Tables) [Line Items]  
Schedule of Warrants Transactions The following table summarizes information about stock options outstanding as of March 31, 2024:
Shares underlying outstanding options (non-vested)  Shares underlying outstanding options (fully vested) 
Range of
exercise
price
  Number
outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
   Range of
exercise
price
   Number
Outstanding
   Weighted
average
remaining
contractual
life (years)
   Weighted
Average
Exercise
price
 
US$          US$   US$           US$ 
0.07   7,005,000    9.48    0.07                 
   
    
    
    0.01    5,000    0.20    0.01 
   
    
    
    0.01    20,000    2.18    0.01 
   
    
    
    0.01    130,000    2.76    0.01 
   
    
    
    0.01    50,000    2.76    0.01 
   
    
    
    0.01    60,000    3.05    0.01 
   
    
    
    0.01    200,000    3.14    0.01 
   
    
    
    0.01    40,000    3.50    0.01 
   
    
    
    0.01    70,000    3.76    0.01 
   
    
    
    0.01    25,000    3.76    0.01 
   
    
    
    0.01    30,000    3.92    0.01 
   
    
    
    0.01    4,000    4.02    0.01 
   
    
    
    0.01    25,000    4.77    0.01 
   
    
    
    0.01    35,000    5.47    0.01 
   
    
    
    0.01    150,000    5.64    0.01 
   
    
    
    0.01    35,000    5.77    0.01 
   
    
    
    0.01    75,000    6.77    0.01 
   
    
    
    0.01    200,000    7.14    0.01 
   
    
    
    0.01    300,000    7.30    0.01 
   
    
    
    0.01    10,000    7.42    0.01 
   
    
    
    0.01    500,000    7.77    0.01 
   
    
    
    0.01    55,000    7.80    0.01 
   
    
    
    0.01    960,000    8.05    0.01 
   
    
    
    0.01    75,000    8.37    0.01 
   
    
    
    0.01    10,000    8.43    0.01 
   
    
    
    0.01    795,000    8.49    0.01 
               0.01    25,000    8.77    0.01 
               0.01    10,000    9.43    0.01 
               0.01    895,000    9.48    0.01 
               0.01    25,000    9.77    0.01 
   
    
    
    0.06    50,000    8.77    0.06 
   
    
    
    0.07    25,000    9.19    0.07 
               0.07    125,000    9.77    0.07 
   
    
    
    0.14    240,000    7.80    0.14 
   
    
    
    0.15    3,200,000    7.77    0.15 
               0.15    6,389,325    8.05    0.15 
   
    
    
    0.16    340,000    1.70    0.16 
   
    
    
    0.16    75,000    5.70    0.16 
   
    
    
    0.18    25,000    1.67    0.18 
               0.18    5,155,000    8.49    0.18 
   
    
    
    0.24    25,000    8.34    0.24 
   
    
    
    0.24    118,000    8.37    0.24 
   
    
    
    0.25    50,000    7.42    0.25 
   
    
    
    0.25    363,000    7.42    0.25 
   
    
    
    0.28    25,000    1.43    0.28 
               0.28    25,000    5.43    0.28 
   
    
    
    0.29    25,000    3.21    0.29 
   
    
    
    0.39    1,435,000    7.28    0.39 
   
    
    
    0.59    1,400,000    3.14    0.59 
   
    
    
    0.59    1,600,000    7.14    0.59 
   
    
    
    0.92    350,000    2.76    0.92 
   
    
    
    0.92    550,000    6.77    0.92 
   
    
    
    1.38    105,307    0.76    1.38 
   
    
    
    1.67    405,943    0.50    1.67 
   
    
    
    1.78    25,000    0.43    1.78 
   
    
    
    4.15    25,000    0.25    4.15 
0.07   7,005,000    
 
    0.07    0.01-4.15    26,965,575         
0.25

  

v3.24.1.u1
Unproved Oil and Gas Properties, Full Cost Method (Tables)
3 Months Ended
Mar. 31, 2024
Unproved Oil and Gas Properties, Full Cost Method [Abstract]  
Schedule of Unproved Oil and Gas Properties Unproved oil and gas properties, under the full cost method, are comprised as follows:
   March 31,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   2,592    2,538 
Capitalized salary costs   2,470    2,444 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   10,424    10,198 
Other costs   39    39 
    16,943    16,637 
Schedule of Post-Impairment of Unproved Oil and Gas Properties Post-impairment of unproved oil and gas properties comprised as follows:
   For the three months ended
March 31,
 
   2024   2023 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   
        -
    11 
Capitalized salary costs   
-
    
-
 
Capitalized interest costs   
-
    
-
 
Legal and seismic costs, license fees and other preparation costs   
-
    34 
    
-
    45 
Schedule of Changes in Unproved Oil and Gas Properties Changes in Unproved oil and gas properties during the three months ended March 31, 2024 and 2023 are as follows:
   March 31,
2024
   March 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:          
Drilling costs, and other operational related costs   54    63 
Capitalized salary costs   26    26 
Capitalized interest costs   
-
    
-
 
Legal and seismic costs, license fees and other preparation costs   226    124 
Other costs   
-
    
-
 
Impairment of unproved oil and gas properties   
-
    (45)
    *306   *168
* Inclusive of non-cash amounts of approximately $664,000, and $1,515,000 during the three months ended March 31, 2024, and 2023, respectively
v3.24.1.u1
Right of Use Lease Assets and Lease Obligations (Tables)
3 Months Ended
Mar. 31, 2024
Right of Use Lease Assets and Lease Obligations [Abstract]  
Schedule of Operating Lease Assets and Liabilities The table below presents the operating lease assets and liabilities recognized on the balance sheets as of March 31, 2024 and December 31, 2023:
   March 31,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Operating lease assets  $956   $194 
           
Operating lease liabilities:          
Current operating lease liabilities  $224   $167 
Non-current operating lease liabilities  $708   $24 
Total operating lease liabilities  $932   $191 
Schedule of Weighted Average Remaining Lease Term and Weighted Average Discount Rate The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of March 31, 2024 are:
   March 31,
2024
 
Weighted average remaining lease term (years)   6.00 
Weighted average discount rate   7.62%

 

Schedule of Future Minimum Lease Payments The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of March 31, 2024:
   US$
thousands
 
2024   281 
2025   156 
2026   155 
2027   150 
2028   150 
Thereafter   275 
Total undiscounted future minimum lease payments   1,167 
Less: portion representing imputed interest   (235)
Total undiscounted future minimum lease payments   932 
v3.24.1.u1
Nature of Operations, Basis of Presentation and Going Concern (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Sep. 14, 2023
a
Sep. 14, 2023
km²
Nature of Operations, Basis of Presentation and Going Concern [Line Items]          
Net loss $ (1,762) $ (2,139)      
Accumulated deficit $ (288,321)   $ (286,559)    
New Megiddo Valleys License [Member]          
Nature of Operations, Basis of Presentation and Going Concern [Line Items]          
Area of land       75,000 302
v3.24.1.u1
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Apr. 02, 2018
Summary of Significant Accounting Policies [Line Items]        
Common stock, par value (in Dollars per share) $ 0.01   $ 0.01 $ 0.01
Diluted net loss per share (in Shares) 26,965,575 14,901,250    
Impairment charge to its unproved oil and gas properties $ 45,000    
Capitalized exploration costs 16,943,000   $ 16,637,000  
Related equipment and spare parts purchase price 5,600,000      
Allocated in spare parts 540,000      
Allocated in additional separate assets $ 48,000      
Warrant [Member]        
Summary of Significant Accounting Policies [Line Items]        
Diluted net loss per share (in Shares) 29,456,952 35,096,362    
v3.24.1.u1
Summary of Significant Accounting Policies (Details) - Schedule of Drilling Rig & Associated Equipment
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Property, Plant and Equipment [Line Items]  
Balance Beginning $ 5,510
Ending Beginning 5,319
Asset Additions
Asset Depreciation (191)
Asset Disposals for Self-Consumption
I-35 Drilling Rig [Member]  
Property, Plant and Equipment [Line Items]  
Balance Beginning 4,591
Ending Beginning 4,432
Asset Additions
Asset Depreciation (159)
Asset Disposals for Self-Consumption
Rig Spare Parts [Member]  
Property, Plant and Equipment [Line Items]  
Balance Beginning 608
Ending Beginning 608
Asset Additions
Asset Depreciation
Asset Disposals for Self-Consumption
Other Drilling Assets [Member]  
Property, Plant and Equipment [Line Items]  
Balance Beginning 311
Ending Beginning 279
Asset Additions
Asset Depreciation (32)
Asset Disposals for Self-Consumption
v3.24.1.u1
Stockholders' Equity (Details) - Part-1 - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Jun. 07, 2023
Apr. 02, 2018
Stockholders' Equity [Line Items]        
Common stock par value $ 0.01 $ 0.01   $ 0.01
Shares authorized to issue (in Shares) 1,200,000,000 1,200,000,000    
Minimum [Member]        
Stockholders' Equity [Line Items]        
Shares authorized to issue (in Shares)     800,000,000  
Maximum [Member]        
Stockholders' Equity [Line Items]        
Shares authorized to issue (in Shares)     1,200,000,000  
v3.24.1.u1
Stockholders' Equity (Details) - Part-2 - USD ($)
3 Months Ended
Jun. 09, 2021
Mar. 31, 2024
Mar. 31, 2023
Stockholders' Equity [Line Items]      
Fair value of stock options granted (in Dollars)   $ 9,000  
Four Senior Officers and Nine Staff [Member]      
Stockholders' Equity [Line Items]      
Stock option plan, exercisable date   not to exceed ten years from the date of grant.  
Shares purchased under option plan (in Shares)   175,000  
Share price   $ 0.07  
Five Staff Members and One Senior Officer [Member]      
Stockholders' Equity [Line Items]      
Stock option plan, exercisable date   vested upon grant and are exercisable through January 4, 2034.  
One Staff [Member]      
Stockholders' Equity [Line Items]      
Share price     $ 0.01
One Senior Officer [Member]      
Stockholders' Equity [Line Items]      
Shares purchased under option plan (in Shares)   25,000  
Share price   $ 0.01  
Fair value of stock options granted (in Dollars)     $ 1,500
One Board [Member]      
Stockholders' Equity [Line Items]      
Stock option plan, exercisable date   vested upon grant and are exercisable through January 4, 2034  
Five Senior Officers and One Staff [Member]      
Stockholders' Equity [Line Items]      
Stock option plan, exercisable date   vested upon grant and are exercisable through January 4, 2033.  
Shares purchased under option plan (in Shares)     175,000
Share price     $ 0.0615
Two Zero Two One Omnibus Incentive Stock Option Plan [Member]      
Stockholders' Equity [Line Items]      
Common stock shares (in Shares) 38,000,000    
Options exercisable term 10 years    
2021 Equity Omnibus Plan [Member] | One Staff [Member]      
Stockholders' Equity [Line Items]      
Stock option plan, exercisable date   vested upon grant and are exercisable through January 4, 2033  
Shares purchased under option plan (in Shares)     25,000
Fair value of stock options granted (in Dollars)   $ 11,000  
2021 Equity Omnibus Plan [Member] | One Board [Member]      
Stockholders' Equity [Line Items]      
Fair value of stock options granted (in Dollars)   $ 1,800  
v3.24.1.u1
Stockholders' Equity (Details) - Part-4 - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 01, 2024
Mar. 28, 2024
Dec. 18, 2023
Oct. 19, 2023
Aug. 31, 2023
Aug. 21, 2023
Jun. 16, 2023
Dec. 14, 2022
Mar. 21, 2022
Sep. 15, 2020
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2022
Dec. 31, 2023
Dec. 31, 2021
Apr. 15, 2024
Mar. 15, 2024
Jul. 15, 2023
Jun. 12, 2023
May 16, 2023
Dec. 28, 2022
Jun. 22, 2022
Jun. 02, 2022
Apr. 02, 2018
Stockholders' Equity [Line Items]                                                
Unrecognized compensation cost (in Dollars)                     $ 211,000                          
Extended termination term                 1 year 2 years                            
Sale of Stock, Description of Transaction                   expiration date of February 25, 2021 to February 25, 2023                            
Exercise price per share                     $ 0.25               $ 0.25       $ 0.25  
Cashflow (in Dollars)                         $ 365,000                      
Termination expiration date, description             the Company extended the termination date of the ZNWAQ warrant from July 15, 2023 to September 6, 2023                                  
Equity issuance cost (in Dollars)                     $ 726,000                        
Warrant [Member]                                                
Stockholders' Equity [Line Items]                                                
Extended termination term                   2 years                            
Sale of Stock, Description of Transaction                   expiration date of May 2, 2021 to May 2, 2023                            
Warrant exercise price                               $ 0.25 $ 0.25       $ 0.05     $ 3
Cashflow (in Dollars)                         $ 365,000                      
Termination expiration date, description   the Company extended the termination date of the ZNWAQ warrant from March 31, 2024 to December 31, 2024       the Company extended the termination date of the ZNWAQ warrant from September 6, 2023 to October 31, 2023                                    
ZNWAE warrants [Member]                                                
Stockholders' Equity [Line Items]                                                
Extended termination term                   2 years                            
Sale of Stock, Description of Transaction                   expiration date of May 1, 2021 to May 1, 2023                            
Warrant exercise price                                       $ 1        
ZNWAF Warrant [Member]                                                
Stockholders' Equity [Line Items]                                                
Extended termination term                   2 years                            
Sale of Stock, Description of Transaction                   expiration date of August 14, 2021 to August 14, 2023                            
ZNWAJ Warrant [Member]                                                
Stockholders' Equity [Line Items]                                                
Extended termination term               1 year   2 years                            
Sale of Stock, Description of Transaction                   expiration date of October 29, 2021 to October 29, 2023.                            
ZNWAG [Member]                                                
Stockholders' Equity [Line Items]                                                
Sale of Stock, Description of Transaction               expiration date of January 8, 2023 to January 8, 2024.                                
ZNWAH [Member]                                                
Stockholders' Equity [Line Items]                                                
Extended termination term                   2 years                            
ZNWAH Warrants [Member]                                                
Stockholders' Equity [Line Items]                                                
Sale of Stock, Description of Transaction                   expiration date of April 2, 2021 to April 2, 2023.                            
ZNWAM Warrant [Member]                                                
Stockholders' Equity [Line Items]                                                
Extended termination term                 1 year                              
Sale of Stock, Description of Transaction                 expiration date of July 15, 2022 to July 15, 2023                              
Warrant exercise price                     $ 0.25                          
Exercise price per share                 $ 0.05                              
ZNWAP Warrant [Member]                                                
Stockholders' Equity [Line Items]                                                
Extended termination term                 1 year                              
ZNWAO [Member]                                                
Stockholders' Equity [Line Items]                                                
Warrant exercise price                     0.25             $ 0.05            
Warrant One [Member]                                                
Stockholders' Equity [Line Items]                                                
Termination expiration date, description       the Company extended the termination date of the ZNWAQ warrant from October 31, 2023 to December 31, 2023                                        
Warrant Two [Member]                                                
Stockholders' Equity [Line Items]                                                
Termination expiration date, description     the Company extended the termination date of the ZNWAQ warrant from December 31, 2023 to March 31, 2024                                          
ZNWAR Warrant [Member]                                                
Stockholders' Equity [Line Items]                                                
Warrant exercise price                     0.25                     $ 0.25    
Equity issuance cost (in Dollars)                             $ 115,000                  
OTCQB MARKETPLACE [Member]                                                
Stockholders' Equity [Line Items]                                                
Exercise price per share                     $ 0.25                          
Subsequent Event [Member]                                                
Stockholders' Equity [Line Items]                                                
Maximum purchase (in Dollars) $ 10,000,000                                              
Minimum [Member]                                                
Stockholders' Equity [Line Items]                                                
Percentage of net cash                           54.00%                    
Maximum [Member]                                                
Stockholders' Equity [Line Items]                                                
Percentage of net cash                     59.00%                          
Zion [Member]                                                
Stockholders' Equity [Line Items]                                                
Equity issuance cost (in Dollars)         $ 173,000           $ 816,000                          
Zion [Member] | Minimum [Member]                                                
Stockholders' Equity [Line Items]                                                
Equity issuance cost (in Dollars)                           $ 1,120,000                    
Common Stock [Member]                                                
Stockholders' Equity [Line Items]                                                
Warrant exercise price                     $ 0.25                          
Exercise price per share                     0.25                          
Share price                     1                          
Common Stock [Member] | Warrant [Member]                                                
Stockholders' Equity [Line Items]                                                
Warrant exercise price                     1                          
Common Stock [Member] | ZNWAU Warrants [Member]                                                
Stockholders' Equity [Line Items]                                                
Warrant exercise price                     $ 0.25                          
v3.24.1.u1
Stockholders' Equity (Details) - Part-6
3 Months Ended 12 Months Ended
Sep. 15, 2020
May 29, 2019
Dec. 04, 2018
Apr. 02, 2018
$ / shares
Mar. 31, 2024
USD ($)
$ / shares
$ / item
shares
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
shares
Apr. 15, 2024
$ / shares
Mar. 15, 2024
$ / shares
Jan. 10, 2024
Sep. 10, 2023
$ / shares
Jul. 31, 2023
$ / shares
Jul. 17, 2023
$ / shares
Jul. 13, 2023
$ / shares
Jun. 28, 2023
$ / shares
Jun. 12, 2023
$ / shares
Dec. 28, 2022
$ / shares
Dec. 14, 2022
Jun. 02, 2022
$ / shares
Mar. 21, 2022
Jun. 29, 2018
$ / shares
Stockholders' Equity [Line Items]                                          
Tranches termination amount (in Dollars) | $         $ 7,500,000                                
Additional shares (in Shares) | shares         500                                
Exercise price per share         $ 0.25                     $ 0.25     $ 0.25    
Warrants received (in Shares) | shares         (500)                                
Number of days required to receive warrant         90 years                                
Debt Instrument, Increase (Decrease), Net (in Dollars) | $         $ 50                                
Automatic monthly investments (in Dollars per Item) | $ / item         50                                
Purchase shares of common stock (in Shares) | shares         50                                
Exercise price per Warrant         $ 0.25                                
Price per share         $ 50                                
Amount raised under the DSPP program (in Dollars) | $         $ 3,557,000 $ 792,000                              
Stock issuance costs (in Dollars) | $         3,557,000                                
Equity issuance costs (in Dollars) | $           816,000                              
Net cash provided amount (in Dollars) | $         $ 2,741,000                                
Amount raised DSPP program (in Dollars) | $           $ 1,959,000                              
Common stock par value       $ 0.01 $ 0.01   $ 0.01                            
Subscription price       5                                  
Warrant expiration 2 years 1 year 1 year                                    
Number of share owned (in Shares) | shares             10                            
ZNWAY [Member]                                          
Stockholders' Equity [Line Items]                                          
AMI minimum amount (in Dollars) | $         $ 500                                
OTCQX warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Units of option (in Dollars) | $         $ 250                                
Exercise price per share         $ 0.05                                
Warrant exercise price         $ 0.25                                
ZNWAV Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Number of share purchased (in Shares) | shares         1                                
Warrant exercise price         $ 0.05                   $ 0.05            
ZNWAY [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 0.05           $ 0.05                    
Warrant [Member]                                          
Stockholders' Equity [Line Items]                                          
Units of option (in Dollars) | $         $ 250                                
Warrant exercise price       $ 3       $ 0.25 $ 0.25               $ 0.05        
Investments per unit         $ 50                                
Additional warrant (in Shares) | shares         (50)                                
Warrants received (in Shares) | shares         (100)                                
Purchase shares of common stock (in Shares) | shares         300                                
Expiration term 2 years 1 year               1 year               1 year   1 year  
ZNWAY Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrants received (in Shares) | shares         (250)                                
ZNWAW Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price                           $ 0.05              
ZNWAX Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price                       $ 0.05                  
ZNWAK Warrant [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 0.25                                
ZNWAZ Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Exercise price per share                         $ 0.25                
Warrant exercise price         $ 0.25                                
Purchase shares of common stock (in Shares) | shares         300                                
OTCQB MARKETPLACE [Member]                                          
Stockholders' Equity [Line Items]                                          
Exercise price per share         $ 0.25                                
Common stock price per share         0.25                                
ZNWBA Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Exercise price per share         0.25                                
Warrant exercise price         0.25                                
Investments per unit         $ 50                                
Automatic monthly investments (in Dollars per Item) | $ / item         50                                
Purchase shares of common stock (in Shares) | shares         50                                
Exercise price         $ 0.25                                
Automatic Monthly Investments [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 0.25                                
Purchase shares of common stock (in Shares) | shares         50                                
Subscription Rights Offering [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price                                         $ 3
Proceeds from Issuance Initial Public Offering (in Dollars) | $             $ 3,038,000                            
Expenses from rights offering (in Dollars) | $             $ 243,000                            
ZNWAJ Warrant [Member]                                          
Stockholders' Equity [Line Items]                                          
Termination expiration date, description         expiration date of the Warrants to December 31, 2023.                                
Minimum [Member] | ZNWAY [Member]                                          
Stockholders' Equity [Line Items]                                          
AMI minimum amount (in Dollars) | $         $ 100                                
Extension of Termination Date to January 31, 2024 [Member] | ZNWBA Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 0.25                                
Common Stock [Member]                                          
Stockholders' Equity [Line Items]                                          
Units of option (in Dollars) | $         $ 250                                
Exercise price per share         $ 0.25                                
Warrant exercise price         $ 0.25                                
Option price units (in Dollars per Item) | $ / item         250                                
Common Stock [Member] | OTCQX warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Units of option (in Dollars) | $         $ 250                                
Common Stock [Member] | Warrant [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 1                                
Additional shares (in Shares) | shares         200                                
Common Stock [Member] | ZNWAZ Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 0.25                                
Automatic Monthly Investments ('' AMI'') Program [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         0.25                                
Investments per unit         $ 50                                
Additional warrants (in Shares) | shares         300                                
Price per share         $ 50                                
Minimum price per month         $ 50                                
Automatic Monthly Investments ('' AMI'') Program [Member] | ZNWAY [Member]                                          
Stockholders' Equity [Line Items]                                          
AMI minimum amount (in Dollars) | $         $ 250                                
Automatic Monthly Investments ('' AMI'') Program [Member] | ZNWBA Warrants [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 0.25                                
Unit Option Program [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 0.25                                
Option price units (in Dollars per Item) | $ / item         250                                
ZNWBA Warrants [Member] | Warrant [Member]                                          
Stockholders' Equity [Line Items]                                          
Purchase shares of common stock (in Shares) | shares         50                                
Unit Option [Member]                                          
Stockholders' Equity [Line Items]                                          
Warrant exercise price         $ 0.25                                
v3.24.1.u1
Stockholders' Equity (Details) - Schedule of Stock Option Transactions - Stock Option [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Stockholders' Equity (Details) - Schedule of Stock Option Transactions [Line Items]  
Number of shares, Outstanding, Beginning balance | shares 34,091,250
Weighted Average exercise price, Outstanding, Beginning balance | $ / shares $ 0.23
Number of shares, Granted to employees, officers, directors and others | shares 200,000
Weighted Average exercise price, Granted to employees, officers, directors and others | $ / shares $ 0.07
Number of shares, Expired/Cancelled/Forfeited | shares (250,000)
Weighted Average exercise price, Expired/Cancelled/Forfeited | $ / shares $ 2.31
Number of shares, Exercised | shares (70,675)
Weighted Average exercise price, Exercised | $ / shares $ 0.1
Number of shares, Outstanding, Ending balance | shares 33,970,575
Weighted Average exercise price, Outstanding, Ending balance | $ / shares $ 0.22
Number of shares, Exercisable | shares 26,965,575
Weighted Average exercise price, Exercisable | $ / shares $ 0.25
v3.24.1.u1
Stockholders' Equity (Details) - Schedule of Stock Options Outstanding
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.07
Number Outstanding (in Shares) | shares 7,005,000
Weighted average remaining contractual life (years)
Weighted Average Exercise price $ 0.07
Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding (in Shares) | shares 26,965,575
Weighted average remaining contractual life (years)
Weighted Average Exercise price $ 0.25
Minimum [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price 0.01
Maximum [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price 4.15
Ranges One [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.07
Number Outstanding (in Shares) | shares 7,005,000
Weighted average remaining contractual life (years) 9 years 5 months 23 days
Weighted Average Exercise price $ 0.07
Ranges Two [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 5,000
Weighted average remaining contractual life (years) 2 months 12 days
Weighted Average Exercise price $ 0.01
Ranges Three [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 20,000
Weighted average remaining contractual life (years) 2 years 2 months 4 days
Weighted Average Exercise price $ 0.01
Ranges Four [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 130,000
Weighted average remaining contractual life (years) 2 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Ranges Five [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 50,000
Weighted average remaining contractual life (years) 2 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Ranges Six [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 60,000
Weighted average remaining contractual life (years) 3 years 18 days
Weighted Average Exercise price $ 0.01
Ranges Seven [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Seven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 200,000
Weighted average remaining contractual life (years) 3 years 1 month 20 days
Weighted Average Exercise price $ 0.01
Ranges Eight [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Eight [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 40,000
Weighted average remaining contractual life (years) 3 years 6 months
Weighted Average Exercise price $ 0.01
Ranges Nine [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Nine [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 70,000
Weighted average remaining contractual life (years) 3 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Ranges Ten [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Ten [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 3 years 9 months 3 days
Weighted Average Exercise price $ 0.01
Ranges Eleven [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Eleven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 30,000
Weighted average remaining contractual life (years) 3 years 11 months 1 day
Weighted Average Exercise price $ 0.01
Ranges Twelve [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twelve [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 4,000
Weighted average remaining contractual life (years) 4 years 7 days
Weighted Average Exercise price $ 0.01
Ranges Thirteen [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 4 years 9 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Fourteen [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 35,000
Weighted average remaining contractual life (years) 5 years 5 months 19 days
Weighted Average Exercise price $ 0.01
Ranges Fifteen [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 150,000
Weighted average remaining contractual life (years) 5 years 7 months 20 days
Weighted Average Exercise price $ 0.01
Ranges Sixteen [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Sixteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 35,000
Weighted average remaining contractual life (years) 5 years 9 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Seventeen [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Seventeen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 75,000
Weighted average remaining contractual life (years) 6 years 9 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Eighteen [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Eighteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 200,000
Weighted average remaining contractual life (years) 7 years 1 month 20 days
Weighted Average Exercise price $ 0.01
Ranges Nineteen [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Nineteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 300,000
Weighted average remaining contractual life (years) 7 years 3 months 18 days
Weighted Average Exercise price $ 0.01
Ranges Twenty [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 7 years 5 months 1 day
Weighted Average Exercise price $ 0.01
Ranges Twenty One [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 500,000
Weighted average remaining contractual life (years) 7 years 9 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Two [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 55,000
Weighted average remaining contractual life (years) 7 years 9 months 18 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Three [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 960,000
Weighted average remaining contractual life (years) 8 years 18 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Four [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 75,000
Weighted average remaining contractual life (years) 8 years 4 months 13 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Five [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 8 years 5 months 4 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Six [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 795,000
Weighted average remaining contractual life (years) 8 years 5 months 26 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Seven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 8 years 9 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Eight [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 9 years 5 months 4 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Nine [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 895,000
Weighted average remaining contractual life (years) 9 years 5 months 23 days
Weighted Average Exercise price $ 0.01
Ranges Thirty [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 9 years 9 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Thirty One [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.06
Number Outstanding (in Shares) | shares 50,000
Weighted average remaining contractual life (years) 8 years 9 months 7 days
Weighted Average Exercise price $ 0.06
Ranges Thirty Two [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.07
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 9 years 2 months 8 days
Weighted Average Exercise price $ 0.07
Ranges Thirty Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.07
Number Outstanding (in Shares) | shares 125,000
Weighted average remaining contractual life (years) 9 years 9 months 7 days
Weighted Average Exercise price $ 0.07
Ranges Thirty Four [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.14
Number Outstanding (in Shares) | shares 240,000
Weighted average remaining contractual life (years) 7 years 9 months 18 days
Weighted Average Exercise price $ 0.14
Ranges Thirty Five [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.15
Number Outstanding (in Shares) | shares 3,200,000
Weighted average remaining contractual life (years) 7 years 9 months 7 days
Weighted Average Exercise price $ 0.15
Ranges Thirty Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.15
Number Outstanding (in Shares) | shares 6,389,325
Weighted average remaining contractual life (years) 8 years 18 days
Weighted Average Exercise price $ 0.15
Ranges Thirty Seven [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Seven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.16
Number Outstanding (in Shares) | shares 340,000
Weighted average remaining contractual life (years) 1 year 8 months 12 days
Weighted Average Exercise price $ 0.16
Ranges Thirty Eight [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Eight [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.16
Number Outstanding (in Shares) | shares 75,000
Weighted average remaining contractual life (years) 5 years 8 months 12 days
Weighted Average Exercise price $ 0.16
Ranges Thirty Nine [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Nine [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.18
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 1 year 8 months 1 day
Weighted Average Exercise price $ 0.18
Ranges Fourty [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.18
Number Outstanding (in Shares) | shares 5,155,000
Weighted average remaining contractual life (years) 8 years 5 months 26 days
Weighted Average Exercise price $ 0.18
Ranges Fourty One [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.24
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 8 years 4 months 2 days
Weighted Average Exercise price $ 0.24
Ranges Fourty Two [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.24
Number Outstanding (in Shares) | shares 118,000
Weighted average remaining contractual life (years) 8 years 4 months 13 days
Weighted Average Exercise price $ 0.24
Ranges Fourty Three [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.25
Number Outstanding (in Shares) | shares 50,000
Weighted average remaining contractual life (years) 7 years 5 months 1 day
Weighted Average Exercise price $ 0.25
Ranges Fourty Four [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.25
Number Outstanding (in Shares) | shares 363,000
Weighted average remaining contractual life (years) 7 years 5 months 1 day
Weighted Average Exercise price $ 0.25
Ranges Fourty Five [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.28
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 1 year 5 months 4 days
Weighted Average Exercise price $ 0.28
Ranges Fourty Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.28
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 5 years 5 months 4 days
Weighted Average Exercise price $ 0.28
Ranges Fourty Seven [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Seven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.29
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 3 years 2 months 15 days
Weighted Average Exercise price $ 0.29
Ranges Fourty Eight [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Eight [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.39
Number Outstanding (in Shares) | shares 1,435,000
Weighted average remaining contractual life (years) 7 years 3 months 10 days
Weighted Average Exercise price $ 0.39
Ranges Fourty Nine [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Nine [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.59
Number Outstanding (in Shares) | shares 1,400,000
Weighted average remaining contractual life (years) 3 years 1 month 20 days
Weighted Average Exercise price $ 0.59
Ranges Fifty [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.59
Number Outstanding (in Shares) | shares 1,600,000
Weighted average remaining contractual life (years) 7 years 1 month 20 days
Weighted Average Exercise price $ 0.59
Ranges Fifty One [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.92
Number Outstanding (in Shares) | shares 350,000
Weighted average remaining contractual life (years) 2 years 9 months 3 days
Weighted Average Exercise price $ 0.92
Ranges Fifty Two [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.92
Number Outstanding (in Shares) | shares 550,000
Weighted average remaining contractual life (years) 6 years 9 months 7 days
Weighted Average Exercise price $ 0.92
Ranges Fifty Three [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.38
Number Outstanding (in Shares) | shares 105,307
Weighted average remaining contractual life (years) 9 months 3 days
Weighted Average Exercise price $ 1.38
Ranges Fifty Four [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.67
Number Outstanding (in Shares) | shares 405,943
Weighted average remaining contractual life (years) 6 months
Weighted Average Exercise price $ 1.67
Ranges Fifty Five [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.78
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 5 months 4 days
Weighted Average Exercise price $ 1.78
Ranges Fifty Six [Member] | Non-vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number Outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 4.15
Number Outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 3 months
Weighted Average Exercise price $ 4.15
v3.24.1.u1
Stockholders' Equity (Details) - Schedule of Weighted-Average Fair Value of Options Granted - Employee [Member] - $ / shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Stockholders' Equity (Details) - Schedule of Weighted-Average Fair Value of Options Granted [Line Items]    
Weighted-average fair value of underlying stock at grant date (in Dollars per share) $ 0.07 $ 0.06
Dividend yields
Expected volatility 133.00% 137.00%
Risk-free interest rates 3.97% 3.85%
Expected lives (in years) 5 years 5 years
Weighted-average grant date fair value (in Dollars per share) $ 0.07 $ 0.06
v3.24.1.u1
Stockholders' Equity (Details) - Schedule of Compensation Cost of Warrant and Option Issuances - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Employees and Directors [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation cost of warrant and option issuances $ 122 $ 415
Non-Employees [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation cost of warrant and option issuances 1 2
Employees and Non Employees [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation cost of warrant and option issuances
v3.24.1.u1
Stockholders' Equity (Details) - Schedule of Warrants Transactions
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Schedule of Warrants Transactions [Line Items]  
Outstanding warrants 29,697,020
Warrants Issued
Warrants Exercised
Warrants Expired (240,068)
Outstanding warrants 29,456,952
ZNWAZ Warrant [Member]  
Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 0.25
Warrant Transactions [Member] | ZNWAA Warrants [Member]  
Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 2
Warrant Termination Date Jan. 31, 2025
Outstanding warrants 1,498,804
Warrants Issued
Warrants Exercised
Warrants Expired
Outstanding warrants 1,498,804
Warrant Transactions [Member] | ZNWAN Warrants [Member]  
Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 1
Warrant Termination Date Jan. 08, 2024
Outstanding warrants 240,068
Warrants Issued
Warrants Exercised
Warrants Expired (240,068)
Outstanding warrants
Warrant Transactions [Member] | ZNWAM [Member]  
Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 0.05
Warrant Termination Date Dec. 31, 2024
Outstanding warrants 4,376,000
Warrants Issued
Warrants Exercised
Warrants Expired
Outstanding warrants 4,376,000
Warrant Transactions [Member] | ZNWAY Warrant [Member]  
Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 0.05
Warrant Termination Date Dec. 31, 2024
Outstanding warrants 23,428,348
Warrants Issued
Warrants Exercised
Warrants Expired
Outstanding warrants 23,428,348
Warrant Transactions [Member] | ZNWAZ Warrant [Member]  
Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 0.25
Warrant Termination Date Jul. 17, 2024
Outstanding warrants 153,800
Warrants Exercised
Warrants Expired
Outstanding warrants 153,800
v3.24.1.u1
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration - Investor [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
ZNWAA Warrants [Member]  
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant March 2013 – December 2014 [1],[2],[3],[4]
Exercise Price $ 2 [1],[2],[3],[4]
Expiration Date January 31, 2025 [1],[2],[3],[4]
ZNWAM Warrants [Member]  
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant January 2021 – March 2021 [5],[6],[7],[8]
Exercise Price $ 0.05 [5],[6],[7],[8]
Expiration Date December 31, 2024 [5],[6],[7],[8]
ZNWAQ Warrants [Member]  
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant June 2021 [5],[6],[7],[8]
Exercise Price $ 0.05 [5],[6],[8]
Expiration Date December 31, 2024 [5],[6],[8]
ZNWAS Warrants [Member]  
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant August 2021 – March 2022 [9]
Exercise Price $ 0.25 [9]
Expiration Date December 31, 2025 [9]
ZNWAT Warrants [Member]  
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant August – September 2022 [9]
Exercise Price $ 0.25 [9]
Expiration Date December 31, 2025 [9]
ZNWAU Warrants [Member]  
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant October – November 2022 [9]
Exercise Price $ 0.25 [9]
Expiration Date December 31, 2025 [9]
ZNWAZ Warrants [Member]  
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant May – June 2023 [10]
Exercise Price $ 0.25 [10]
Expiration Date July 17, 2024 [10]
ZNWBA Warrants [Member]  
Stockholders' Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant November – December 2023 [11]
Exercise Price $ 0.25 [11]
Expiration Date June 15, 2025 [11]
[1] On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year.
[2] On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year.
[3] On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year.
[4] On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years.
[5] On December 18, 2023, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to March 31, 2024.
[6] On March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023.
[7] On March 23, 2024, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to December 31, 2024.
[8] The warrant exercise price was lowered to $0.05 on December 28, 2022.
[9] These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025.
[10] On May 15, 2023, the Company announced a new Unit Offering and the related ZNWAZ warrant.
[11] On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant.
v3.24.1.u1
Unproved Oil and Gas Properties, Full Cost Method (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Unproved Oil and Gas Properties, Full Cost Method [Abstract]    
Inclusive of non-cash amounts $ 664,000 $ 1,515,000
v3.24.1.u1
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of Unproved Oil and Gas Properties - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Excluded from amortization base:    
Drilling costs, and other operational related costs $ 2,592 $ 2,538
Capitalized salary costs 2,470 2,444
Capitalized interest costs 1,418 1,418
Legal and seismic costs, license fees and other preparation costs 10,424 10,198
Other costs 39 39
Unproved oil and gas properties, full cost method $ 16,943 $ 16,637
v3.24.1.u1
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of Post-Impairment of Unproved Oil and Gas Properties - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Excluded from amortization base:    
Drilling costs, and other operational related costs $ 11
Capitalized salary costs
Capitalized interest costs
Legal and seismic costs, license fees and other preparation costs 34
Total of post-impairment of unproved oil and gas properties $ 45
v3.24.1.u1
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of Changes in Unproved Oil and Gas Properties - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Excluded from amortization base:    
Drilling costs, and other operational related costs $ 54 $ 63
Capitalized salary costs 26 26
Capitalized interest costs
Legal and seismic costs, license fees and other preparation costs 226 124
Other costs
Impairment of unproved oil and gas properties (45)
Total unproved oil and gas properties [1] $ 306 $ 168
[1] Inclusive of non-cash amounts of approximately $664,000, and $1,515,000 during the three months ended March 31, 2024, and 2023, respectively
v3.24.1.u1
Right of Use Lease Assets and Lease Obligations (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
ft²
Mar. 31, 2023
USD ($)
Right of Use Lease Assets and Lease Obligations [Line Items]    
Lease agreement description The Company had an option to renew the lease for another five years from February 1, 2024 to January 31, 2029, provided it is not in breach of the agreement, where it is required as well to furnish a notice of intent to exercise the option six months prior to termination of lease, and it furnishes a bank guarantee and insurance confirmation prior to commencement of the option period. The Company exercised the option to renew the lease for another seven years from February 1, 2024 through January 31, 2031, when rent is to be paid on a monthly basis in the base amount of approximately NIS 46,500 per month (approximately $12,800) at the exchange rate in effect on the date of this report and is linked to an increase (but not a decrease) in the CPI.  
Operating lease costs $ 75,000 $ 69,000
Operating lease liabilities 88,000 70,000
Right of Use Assets [Member]    
Right of Use Lease Assets and Lease Obligations [Line Items]    
Operating lease liabilities $ 829
Caesarea, Israel [Member]    
Right of Use Lease Assets and Lease Obligations [Line Items]    
Number of square feet (in Square Feet) | ft² 6,566  
v3.24.1.u1
Right of Use Lease Assets and Lease Obligations (Details) - Schedule of Operating Lease Assets and Liabilities - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Schedule of Operating Lease Assets and Liabilities [Abstract]    
Operating lease assets $ 956 $ 194
Operating lease liabilities:    
Current operating lease liabilities 224 167
Non-current operating lease liabilities 708 24
Total operating lease liabilities $ 932 $ 191
v3.24.1.u1
Right of Use Lease Assets and Lease Obligations (Details) - Schedule of Weighted Average Remaining Lease Term and Weighted Average Discount Rate
Mar. 31, 2024
Schedule of Weighted Average Remaining Lease Term and Weighted Average Discount Rate for Operating Leases [Abstract]  
Weighted average remaining lease term (years) 6 years
Weighted average discount rate 7.62%
v3.24.1.u1
Right of Use Lease Assets and Lease Obligations (Details) - Schedule of Future Minimum Lease Payments - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Schedule of Future Minimum Lease Payments [Abstract]    
2024 $ 281  
2025 156  
2026 155  
2027 150  
2028 150  
Thereafter 275  
Total undiscounted future minimum lease payments 1,167  
Less: portion representing imputed interest (235)  
Total undiscounted future minimum lease payments $ 932 $ 191
v3.24.1.u1
Commitments and Contingencies (Details) - USD ($)
3 Months Ended 12 Months Ended
Apr. 12, 2024
Feb. 23, 2024
Jan. 28, 2024
Dec. 16, 2023
Dec. 13, 2023
Nov. 16, 2023
Mar. 31, 2024
Dec. 31, 2023
Mar. 12, 2024
Dec. 28, 2023
Mar. 31, 2023
Commitments and Contingencies (Details) [Line Items]                      
Accrued license                  
Total premiums, taxes and fees           $ 76,263     $ 94,989 $ 441,598  
Cash down payment   $ 37,637     $ 68,733 $ 22,699          
Insurance financing, payments     $ 37,287 $ 5,356              
Rate of interest     13.40% 13.99%              
Due month     10 months 10 months              
Outstanding amount, insurance financing             388,000       $ 432,000
Bank guarantees to government             944,000        
Bank guarantees to others             87,000        
Bank guarantee amount             $ 1,031,000        
Percentage of currency inflation             1.50% 3.10%      
Cash, cash equivalents and short-term bank deposits               $ 2,146,000      
Fund interest rate percentage             3.20%        
Subsequent Event [Member]                      
Commitments and Contingencies (Details) [Line Items]                      
Insurance financing, payments $ 9,499                    
Rate of interest 13.99%                    
Due month 10 months                    
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Four Suppliers [Member]                      
Commitments and Contingencies (Details) [Line Items]                      
Concentration of credit risk             10.00%        
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Three Suppliers [Member]                      
Commitments and Contingencies (Details) [Line Items]                      
Concentration of credit risk             10.00%        
v3.24.1.u1
Subsequent Events (Details)
1 Months Ended
May 07, 2024
USD ($)
Subsequent Event [Member] | DSPP Program [Member]  
Subsequent Events [Line Items]  
Amount collected $ 1,959,000

Zion Oil and Gas (PK) (USOTC:ZNOGW)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Zion Oil and Gas (PK) Charts.
Zion Oil and Gas (PK) (USOTC:ZNOGW)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Zion Oil and Gas (PK) Charts.